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Engineered ligament for anterior cruciate ligament (ACL) regeneration had been 
much studied currently, however it had the problems of lack of bone tunnel 
mineralization and missing the integration of the graft with the surrounding bone, 
which made the regenerated ligament unable to restore total mechanical functions.  In 
native and normal ACL, the bone-ligament interface existed, which was a multiple 
tissue structure made up of bone, fibrocartilage and ligament. Moreover, the 
fibrocartilage was made up of both calcified fibrocartilage near to bone and 
uncalcified fibrocartilage near to ligament. This transitional structure contributed to 
the smooth transfer of the mechanical force from hard tissue to soft tissue.  
Based on this anatomy review, it was believed that a bio-mimic bone-ligament 
interface was important to be generated in order to achieve total functional 
regeneration of ACL. Therefore it was hypothesized to engineer a bone-ligament 
interface in vitro by making use of the multi-potent bone marrow-derived stem cell 
(BMSC) as well as different bio-molecular cued scaffolds. Under this hypothesis, it 
was further proposed to achieve this bio-mimic interface by firstly inducing the 
BMSC tri-lineage pre-differentiation on different growth factor loaded composite silk 
fibroin scaffolds and individual induced medium also, then integrating of the tri-
lineage pre-differentiated BMSC into one scaffold complex and finally co-culturing of 
the tri-lineage under one common medium to form a transitional interface made up of 
both calcified and uncalcified fibrocartilage. 
In order to prove this hypothesis and successfully engineered this bio-mimic interface 
in vitro, total four stages of experiment were conducted. In 1
st
 stage, it was proven 
that BMSC could be the only cell source to support the in vitro bone-ligament 
vi 
 
interface regeneration through 2D tri-lineage study. Besides, the different culture 
medium was investigated and found that BMSC tri-lineage pre-differentiation for 
interface regeneration had to take in individually induced medium first even with the 
growth factor supplements.  
In 2
nd
 stage, a silk fibroin based composite scaffold embedded with growth factor 
loaded gelatine microspheres was fabricated and further characterized with their 
biocompatibility and growth factor release profile. The results not only proved that 
this composite scaffold system could well support cell attachment and proliferation 
but also demonstrated the sustainability of releasing the growth factors.  
In stage 3, BMSC 3D tri-lineage pre-differentiation was tested on three different 
growth factor loaded composite scaffolds. Two different loading of growth factor was 
investigated for each lineage pre-differentiation. All the tri-lineage pre-differentiation 
was successfully induced in terms of both gene expression and histology (or 
immnuohistochemistry) staining results.  Moreover, it was found that higher loading 
of growth factor could better enhance the differentiation. 
Last but not least, in stage 4 the tri-lineage pre-differentiated BMSC were integrated 
into one scaffold complex by suturing them using the degummed silk fiber, in a 
manner that chondrogenic BMSC stayed in middle, and the left half was in direct 
contact and overlapping with the osteogenic BMSC while the right half was in direct 
contact and overlapping with fibroblastic BMSC. Then the integrated scaffold 
complex was co-cultured in common proliferative culture medium for another 3 
weeks to allow further differentiation and also formation of the transitional interface 
by calcification of left chondrogenic part under direct contact with osteogenic part.  
Both gene expression and histological (or immunohistochemistry) staining results 
vii 
 
confirmed the maintaining of the further differentiation for the tri-lineage BMSC 
except that there was down-regulation of the fibrocartilage gene markers for both half 
parts of co-cultured chondrogenic scaffolds. But the hypertrophic fibrocartilage gene 
markers was significantly up regulated and obvious staining of  Col X was also found 
in the left half part of chondrogenic scaffold, indicating the calcification happening in 
the left half part after co-culturing with osteogenic BMSC. Alizarin red staining 
further showed that the calcium deposition was obviously detected in the left part as 
compared to the right half part co-cultured with fibroblastic part, confirming the 
calcification of the left chondrogenic part and the formation of the transitional 
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Chapter 1 Introduction 
  
1.1  Background 
1.1.1 Anatomy, Function and Injury of the Anterior Cruciate Ligament  
Ligament is a soft tissue made up of bands of collagenous fibers, connecting from 
bone to bone. It is varied in size, shape, orientation depending on different anatomy 
size. The main function of ligament is to guide and stabilize the movement of 
joint[1].Anterior cruciate ligament(ACL) is one of the pair ligaments in the knee 
joints, which courses from the lateral femoral condyle to the medial tibial condyle and 
form a cross structure with the posterior cruciate ligament, as indicated in the 
Figure1.1. It helps the stabilization of the knee joint by preventing the translation and 
rotational motion of the femurs and tibia.[2]  
 
Figure 1.1:  Anatomy of the Knee Joint[3] 
Recently, it is reported the fiber bundles in the ACL are not isometric but made of two 
different bundles which are anteromedial (AM) and posterolateral (PL) according to 
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the insertion site in the tibias. Moreover, the two bundles have different tensioning 
pattern throughout the knee flexion [4] 
It is founded that most of the ACL injury is caused by the sports practice, such as 
playing soccer, basketball. And among the injuries, non-contact injuries are more than 
the contact injuries, accounting for 70% of the incidents[3]. Besides, the female 
athletes are more susceptible to the ACL injuries as compared to the male 
counterparts[3, 5]. And it is estimated that there are around 80,000-10,000 ACL 
reconstructions annually in united states[3].  
1.1.2 Clinical Treatment of ACL Injury 
Since the ACL has very poor regeneration capacity due to the lack of vascularization, 
the prevalent treatment of the ACL injury in the clinical practice is the surgery 
implantation of biological graft into the patients, such as allograft. However, the 
allograft may face the problem of disease transmission, inflammation or immune-
response, mismatch of the size or limited donor source[6]. Also, the sterilization of 
the allograft is a problem which weakens the property of the tissue[7] Therefore, in 
clinical application, the autograft implantation is more widely operated. And two 
main sources for the autograft are patellar tendon or hamstring tendon autografts[8] 
Moreover, the research finds that the two bundles tendon autografts instead of single-
bundles grafts are more popularly used nowadays since it mimicks the native ACL 
anatomy[9] 
However, there are still limitations using the autografts. First, it may cause second 
injury to the knee joint. Second, the anchoring of the autografts in the femur and tibia 
bone tunnels remains challenging. Third, the size of the autograft may not fit the 
injure site due to the limited availability of the native patellar tendon. Even the bone-
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patellar tendon-bone graft, known as the gold standard for ACL reconstruction proves 
to have least measureable laxity, fastest graft incorporation and lowest failure rates 
[10], there are still drawbacks due to the donor site morbidity[11].  
There are also some reported studies using the synthetic graft to replace the autografts 
for ACL reconstruction to compromise the problem of donor site morbidity. Among 
all the synthetic graft materials, Carbon fiber, polypropylene, Dacron and polyester 
are main substitutes.[7] The artificial graft made of Carbon fiber was firstly developed 
by Jenkins et al in 1977[7, 12] and implanted by Dandy et al in 1981[7, 13]. But the 
grafts faces the problem of poor mechanical properties of torsion force, which leads to 
the rupture of the fiber and carbon deposit in the joints, finally causing the 
inflammation to the body[7, 14]. Then the Gore-Tex graft made up of 
polytetrafluorethylene (PTFE) and Dacron graft made up of polyester was developed 
and approved by FDA for implantation for ACL reconstruction by the advantage of 
very high ultimate tensile strength and stiffness as compared to native ACL. Short-
term success was achieved for this graft, but the problem with long-term success 
existed with the mechanical fatigue arising from no tissue in-growth as well as the 
wear debris[7].  
1.1.3 Ligament Tissue Engineering 
Due to the limitation of the direct graft implantation, tissue engineering of ligament 
becomes a promising method for ACL reconstruction by promoting the tissue in-
growth. Successful tissue engineering requires three elements, the biocompatible 
scaffold, the appropriate cell source and the stimulated factors[15].  
Although the primary fibroblasts are the specialized cell type in the ligaments and 
producing the extra cellular matrix component for the ligament[16], but more research 
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show that the mesenchymal stem cell can be differentiated into fibroblastic cells for 
ligament regeneration and has a better proliferation rate and collagen production than 
fibroblast[15, 17, 18]. 
In selection of biocompatible materials as scaffold, the collagen which mimics the 
native component of extra-cellular matrix of ligament was used in early times, but 
they show poor mechanical properties as well as fast degradation, which make them 
inappropriate for the long term process of ligament regeneration. Although 
crosslinking the collagen is done later to improve the mechanical strength as well 
slow down the degradation, but it causes new problem of introducing the toxicity 
organic residuals, such as glutaraldehyde[19].  The synthetic polymers, such as 
poly(L-Lactic Acid) (PLA), polycarprolactone (PCL) and poly(lactide-co-glycolide) 
(PLGA) have been widely used due to the improved mechanical properties and low 
degradation rate[19-21]. And they are designed into different morphology, such as 
biomimetic 3D braided twist structure [21, 22], which show significant increase in 
ultimate tensile strength. The other included the woven or knitted structure, which 
shows high porosity than braid-twist, therefore allowing better cell infiltration[19]. 
Recently with the technique of electrospinning, the nanofibers appear as an attractive 
alternate structure for ACL scaffold since the nanoscale diameter of fibers mimics the 
actual scale of the native ECM and the large surface to volume ratio also allows 
maximum cell attachment[23].  It was reported in Sambit’s work that the electrunspin 
PLGA nanofiber onto the knitted PLGA microfiber increased the cell seeding 
efficiency and proliferate rate largely for BMSC fibroblastic differentiation for 
ligament regeneration[24]. In the work of Surrao, the wavy, crimp-like electrospun 
PLA based nanofiber was produced by incubating the fiber in a heated aqueous 
solution overnight after electrospininng. This crimp-like pattern matched the 
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wavelength and amplitude of the native ACL collagen fiber and therefore mimicked 
the native-like micro-environment for cell niche[25].  However, the different 
morphology pattern of the synthetic polymers cannot compromise the intrinsic inert 
properties as well as the hydrophobicity of the materials[19], which made them not 
the optimal candidates for tissue engineered ACL scaffold. 
The silk fibroin, which was protein-based biomaterial, comes as a very promising 
candidate for ligament tissue engineering due to good biocompability, slow 
degradation, and superior mechanical strength[26]. The silk fiber source from 
domestic Bombyx mori was very biocompatible after removing the outside layer of 
sericine by degumming them in the sodium carbonate solution, only leaving the silk 
fibroin core inside. And the β sheet structure made them semi-crystalline, therefore 
degrading very slowly in physiological condition. And the intrinsic elastic properties 
of the silk fibroin fiber allowed them to stand for very high tensile force which is 
required for the ACL reconstruction and function. And the silk fibroin based scaffold 
was also reported to be fabricated in different geometry. Altman et al made a silk 
scaffold by paralleling binding 6 cords of silk fibers and it demonstrated a 
comparative ultimate tensile force with native ACL[26]. Besides, our research group 
has developed a hybrid knitted silk fiber scaffold with lyophilized silk fibroin sponge 
in the opening. This morphology not only gave the scaffold good mechanical 
properties, but also allowed high cell seeding efficiency and proliferation since the 
knitted silk fiber behaved as a good mechanical support while the sponge served as a 
good chemical support for the cell adhesion[27].  
 In our previous laboratory research work, there was already reported successfully 
regeneration of ACL either in large pig animal models using the combined silk 
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scaffold graft seeded with bone marrow stem cell [28, 29], as seen in the Figure 1.2  
the gross observation of the regenerated ACL in pigs. 
 
Figure 1.2: Gross Observation of the Regenerated ACL in the Pigs [29] 
In biomechanical test, these regenerated ACL can bear around 50% of the maximal 
load in the native ACL. However, since it only focused on the ligament graft alone, 
the bone tunnel mineralization was scarce as indicated the micro-CT scanning, as 
shown in Figure 1.3, which leaded to the poor fixation of the graft and poor 
integration of the ligament with the bone interface. In the end, the ACL function 
couldn’t  be totally restored.  
 
Figure 1.3: Micro-CT images of implant-bone junction in femoral bone tunnels (A,C) 
and tibial bone tunnels (B) in experiment group (A,B) and control group (C,D) at 




1.1.4 Ligament to bone healing 
As there was problem with the ligament-alone graft by the tissue engineering method, 
people started to focus on how to improve the ligament to bone healing at the bony 
ends. Since during the process of the implantation of the ACL graft, the holes would 
be drilled in both the tibia and femur ends, and then passing through the tissue 
engineered graft. 
During the healing process, there was very scare recovery from the soft ligament 
tissue to the hard bone tissue, lack of forming the biological fixation, therefore 
leading to the poor integration of the graft with the bone.  
Several methods had been used to enhance the osteointegration of the graft. Bone 
substitutes was reported to fill the bone-ligament interface using coating graft with 
calcium phosphate based cements, which made the graft more osteoconductive. And 
the results showing the healing process accelerated and the neo bone formation was 
detected in rabbit ACL insertion site as early as 2 weeks after surgery and the 
cartilage like layer was also partially observed at third week after the operation[30]. 
But since the whole graft was coated with the cements, it may not be appropriate for 
the ligament part alone regeneration. Further optimization of the graft was needed.  
Besides, the autologus periosteum parch was wrapped around the graft ends and 
transplanted together into the joint to enhance the bone-ligament interface 
regeneration. It was hypothesized by some people that the periosteum parch enhance 
the osteointergration by providing the undifferentiated progenitor cell, as well as the 
growth factors for the ligament to bone healing and furthermore, the periosteum itself 
acted as the matrix for cell recruitment and attachment[31]. In a study reported by 
Chen et al, it was founded that the new bone formation and fibrovascular interface 
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formation occurred only after 4 weeks of post operation, and the bone intergration 
into the tendon as well as the fibrocartilage interface was later detected at 12 weeks, 
after implantation of the periosteum wrapping graft into the rabbit proximal tibal 
tunnels[32]. 
Apart from the surface modification of the graft, some researcher also tried to 
incorporate the growth factor, such as bone morphogenetic proteins, transforming 
growth factors and fibroblastic growth factor into the graft, or some even transplanted 
the stem cell into the graft for in vitro pre-culturing before implantation for the 
surgery[33].  
However, these methods may only focus on the osteointergration of the graft. 
Actually the bone-ligament interface was a complex structure composited of three 
different tissues and functions, which were the bone, fibrocartilage, and ligament, as 
illustrated in the Figure 1.4. And the fibrocartilage was further divided into calcified 
and uncalficed part. The ligament resisted the tensile force, therefore preventing the 
joint rotation and translation, while the bone part stand for the compression exerted on. 
Therefore, the interface fibrocartilage was transferring the tensile force from the 





Figure 1.4: Schematic diagram illustrating the composition of the bone-ligament 
interface[34]. 
 
Based on the native anatomy structure of the complex bone-ligament interface, Helen 
Lu et al proposed a design of the multiphasic or stratified yet continuous scaffold for 
the bone-ligament interface tissue engineering, mimicking the heterogeneous cell and 
matrix composition of the interface. Each layer of the scaffold had different material 
composition as well as different morphology to match the functional and mechanical 
properties. Then they co-cultured different cell types on the stratified scaffold for 
heterogeneous matrix deposition[35]. The in vivo subcutaneous rat model study 
showed there was migration between each cell type and each scaffold layer[36]. 
However their scaffold design didn’t undergo the ACL graft implantation, therefore it 
may not be concluded that this multiphase scaffold design was suitable as a functional 




1.2  Hypothesis 
Based on the native multilayer structure of bone ligament interface, it was 
hypothesized in this project that a bio-mimic bone-ligament graft could be developed 
in vitro by differentiating the multi-potent bone marrow derived stem cell (BMSC) 
into multi-lineage on an 3D composite silk fibroin scaffold which not only gave 
different biochemical factors but also served a good biocompatible support for cell 
proliferation and matrix deposition.  
In more details, tri-lineage differentiation of BMSC can be induced individually on 
different biochemically cued silk fibroin scaffold and then three different tissue-
scaffold complexes would be integrated and tri-cultured with each other and form the 
bio-mimic bone-calcified fibrocartilage-uncalcified fibrocartilage-ligament structure 
in vitro.  








Figure 1.5: schematic diagram showing the hypothesis of in vitro bone-ligament 




1.3  Objectives  
Under this hypothesis, three main objectives are going to be achieved.  
Firstly, multi-potency of BMSC for bone-ligament interface development is going to 
be proved by 2D tri-lineage induced differentiation 
Secondly, a 3D silk based scaffold system is going to be built for the BMSC 3D tri-
lineage differentiation, which not only can sustainably deliver the biochemical cues 
needed for each lineage differentiation, but also serve as good biocompatible support 
for cell proliferation and matrix deposition.  
Last but not least, an integrated bone-ligament construct is going to be developed 




1.4   Scopes 
This thesis consisted of seven chapters. The first chapter introduced the background 
about this project, as well as the hypothesis, objectives and scopes of the thesis.  
The second chapter gave a detailed literature review on the bone-ligament interface 
structure, function as well as the prevalent methods of reconstruction; the silk based 
materials for tissue engineering; the multi-potency of bone marrow derived stem cell 
on tissue engineering; last but not least, the growth factor delivery vehicles for the 
tissue engineering.  
The third to sixth chapter were the main parts covering the experiments. The 3
rd
 
chapter talked about the 2D study of the BMSC for tri-lineage differentiation under 
different induced medium and growth factor concentration. The 4
th
 chapter was about 
the fabrication as well as the characterization of the composite gelatine microspheres 
embedded silk fibroin scaffold as 3D scaffold for BMSC differentiation and growth 
factor delivery. The 5
th
 chapter involved the 3D tri-lineage differentiation of BMSC 
on different growth factor loaded composite scaffold to prove the suitability for bone-
ligament interface reconstruction. The 6
th
 chapter covered the integration of different 
lineage of BMSC on the 3D composite scaffold as well as the co-culture of each 
lineage into the final fibrocatilage interface.  
The 7
th
 chapter, namely the last chapter gave a summary about this thesis work, and 






Chapter 2  Literature Review 
 
2.1  Bone-Ligament Interface 
2.1.1 Attachment of Ligament to Bone: Enthesis 
As introduced in 1
st
 chapter, the ligament to bone healing is vital for functional ACL 
regeneration. Therefore, developing an integrated bone-ligament interface is 
necessary for ligament tissue engineering. Before proposing a good way to build the 
interface, the native composition, function as well as the physiology about the bone-
ligament interface should be learnt about. 
The attachment of the soft tissue ligament or tendon into the hard tissue bone is called 
enthesis[37]. It is divided into two categories depending on the particular attachment, 
direct or indirect. The indirect insertion, also called fibrous insertion, are sites of 
attachment to metaphyseal or diaphyseal bone[38], such as the tibial insertion of MCL, 
in which the ligament attaches to the bone by Sharpey’s like fiber, a perpendicular 
collagen fiber inserting into the bone.  The direct insertion, also called 
fibrocartilaginous entheses, is found on the epiphyses of long bones or on small bones 
such as the carpal and tarsal bones[38], such as the femoral insertion of MCL, in 
which the ligament inserts into the bone through a transition zone[39].  
This transition zone is made up of four different tissues and cell compositions and has 
different mechanical functions therefore. Figure 2.1 illustrates the structure of this 
transition zone[40]. The first layer is the ligament end which is filled by the aligned 
collagen fibril and fibroblasts. The collagen fibril continues to insert into the second 
layer which is the uncalcified fibrocartilage, but the fibril is larger and less aligned to 
each other compared to that in the first layer. Also the cell is avoid-shape and less in 
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quantity. Between the uncalcified fibrocartilage and the third layer, which is the 
calficied fibrocatilage, there is an obvious trademark as a boundary line. The cell in 
the calficed fibrocatilage layer is hypertrophic, highly circular chondrocyte with 
mineralized extra cellular matrix. Following the calcified fibrocartilage, it is the bone 
tissue layer, separated by the interdigitation interface which provides the secure 
attachment between tissues. The osteoblasts, osteoclasts and osteocytes are found as 
usually in this bone tissue layer, together with mineralized collagen I matrix.  
 
Figure2.1: The Schematic Diagram Showing the Different Zones of the 
Fibrocartilagenous Enthesis [40] 
 
The transition zones play an important role in transferring the mechanical force 
between the different layers. The ligament is strong in tension force in native while 
the bones can stand for the compressive force. Without the transition zones, stress 
concentrations are easily formed at the interface where two materials has significant 
different mechanical properties. The fibrocartilageous enthesis, with both calcified 
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and uncalcifed fibrocartilage, is superior in transferring the compressive load in the 
bone to the tensile load in the ligament, therefore bridging the gap of the mechanical 
difference between the hard tissue bone and the soft tissue ligament.  
2.1.2 Development of Fibrocartilaginous Enthesis 
It is believed that the development of fibrocartilagnious interface between the bone 
and ligament is similar to that of subchondral interface, that both are driven by the 
endochondral ossification. The chondrocytes in hyaline cartilage become hypertrophic 
and expressed the collagen type X for mineralization postnatally for 14 days 
according to the in situ hybridization and immunohistochemistry studies of the extra 
cellular matrix pattern in the mouse postnatal enthesis development. [41] 
In Benjamin’s work, it gave a more detailed explanation on the development of 
fibrocartilaginous enthesis. Figure 2.2 explains how the enthesis is formed[37]. In the 
beginning, the tendon or ligament attaches to the hyaline cartilage (a), and then the 
hyaline cartilage is eroded and replaced by bone, through the ossification process, 
same as explained in above paragraph. The hyaline cartilage in the attachment site 
remains as a disc and escaped the ossification (b), but this part is eventually 
completely reabsorbed and replaced by the fibrocatilage (c,d). The development of the 
fibrocatilage is assumed to be driven by the metaphasis in the tendon or ligament and 
the signal for the metaphasis is probably the mechanical loading, especially the 
increased compression and/or shear due to the movement of the ligament relative to 
the bone. So the fibroblast in the ligament changes the phenotype and becomes the 
avoid-shape fibrocartilage cell, aligned in the less parallel collagen fibril, as illustrated 
in Figure 2.2(a,b).   
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This explanation of the enthesis development was also indicated in other work, 
concluded as both the endochondral ossification from hyaline cartilage into the 
calcified fibrocartilage and bone, and the metaphasis from the ligament into the 
fibrocartilage, therefore forming a four layer of multi-tissue organization of 
fibrocartilagnous enthesis [38].  
 
Figure 2.2: Schematic diagram showing the development of the fibrocartilagenous 
enthesis[37] 
 
2.1.3 Immunohistology of Fibrocartilage Enthesis. 
The collagen type I is detected along the whole thickness of the interface, through the 
ligament to the bone. But the arrangement of the collagen I fibrils is different in each 
layer. In the ligament, it is highly aligned and parallel to each other, while in the 
fibrocartilage, it is less parallel and aligned only to some extent. The collagen I in the 
bone is highly mineralized and randomly arranged as illustrated in Figure 2.3 showing 





Figure 2.3: the histology staining of the fibrocartilaginous enthesis[42]. 
The collagen type II and aggrecan are found in the fibrocartilage layer only, but in 
both uncalcified and calcified fibrocartilage, as shown in Figure 2.4 & Figure 2.5. 
Besides, the collagen type X is found only in the calcified fibrocartilage and 
mineralized bone. It is produced by the fibrocartilage cells near the tidemark and 
prevent the calcification further into the tendon and maintain the interface between the 
calcified fibrocartilage and uncalcified fibrocartilage[42]. This was proved by the  
immunohistology study of the enthesis development in rat medial collateral ligament 




Figure 2.4: Immunohistochemistry labelling for type II collagen at the insertion of the 
central slip of the extensor tendon to the base of the middle phalanx of a second 
toe[44]. 
 
Figure2.5:  Immunohistochemistry labelling for aggrecan at the enthesis of the 
common extensor origin[44] 
 
2.1.4 Tissue Engineering Approaches of Development of the Interface 
Due to the avascular intrinsic property of the enthesis, the regeneration of this 
interface is difficult to happen in physiological conditions. Therefore, it is crucial to 
develop this ligament to bone insertion based on tissue engineering approach.   
Since the native tendon/ligament to bone insertion was a transition zone made up of 
multiple tissues with different cell type and extra cellular matrix, having different 
mechanical properties, the tissue engineering approach should take into the 
consideration of the heterogeneous structures.  
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In Thomopoulos’s review[45] on the tissue engineering strategies for tendon/ligament 
to bone insertions, two basic paradigms based on the cell population and stimuli were 
proposed, as illustrated in the Figure 2.6. 
 
Figure 2.6: Two basic paradigms have been established in tendon/ligament-to-bone 
tissue engineering. [45] 
 
The first approach was to seed different cell types which are relevant to the cell 
distribution on the insertion on each stratum of a stratified scaffold, which was then 
held in together in series. It was hypothesized that the different cell type in proximity 
stimulated each other and initiated the cell-mediated metaplasia and finally developed 
into different extra cellular matrix deposition in the stratified scaffold, mimicking the 
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native insertion-like grade structure,  as what had been done in Helen Lu et al’s 
work[34-36], which were discussed in the chapter 1.  
The second approach was to utilize a single pluripotent stem cell that could be 
simulated by the gradient of the stimuli in the scaffold into different lineages. This 
approach was hypothesized that the gradient biochemical and mechanical stimuli 
could promote the local differentiation of stem cell into the desired cell type and 
tissue, similar to insertion-site-like structure and function. Messenchymal stem cell is 
a good cell candidate for this approach due to the easily available source as well as the 
non-immunogenicity. 
Making a gradient of stimuli could be either in the form of biological, chemical or 
mechanical. The electronspun PLGA nanofiber with gradient of calcium phosphate 
coating was fabricated to mimic difference in mineralization in the tendon to bone 
insertion and it showed the difference of cell adhesion and migration along the 
scaffold thickness under the mineral content gradient stimuli[46]. Similarly, the 
protein gradient was also incorporated into the electronspun nanofiber using the same 
method by varying the immersing time. The FITC-labelled fibronectin was coated on 
this scaffold, with difference along the thickness of the nanofiber mat and it also 
showed different cell spreading along protein gradient[47].  The chemical or 
biological factors gradient may serve as good stimuli for gradient cell proliferation 
and differentiation for bone-ligmanet interface developments. Besides, a three 
dimensional scaffold with a gradient in stiffness was also fabricated for functional 
regeneration of the interfacial tissues in Singh’s work. The gradient scaffold was 
made by pumping two different sets of lyophilized microspheres which were 
dispersed in distilled water through two syringes into the cylindrical mold in a 
controllable programming way, and then by sintering using the ethanol treatment for 2 
22 
 
hours. Since this scaffold was made up of two different microspheres, with one 
microsphere made up of PLGA and CaCO3 in ratio of 90:10 and the other being the 
homogenous rodamine B-labelled PLGA microspheres, and the composition of these 
two microspheres was varied along the length of the scaffold, the gradient in the 
stiffness was formed due to the different mechanical properties of the 
microspheres[48].  
2.2  Bone Marrow Derived Stem Cell  
Based on the multi-tissue organization of ligament to bone insertion, the tissue 
engineering strategies for regeneration of the enthesis must consider multiple cell 
types or a pluripotent cell which could be further induced into different lineages.  But 
harvesting multiple cell types, such as fibroblast, chondrocytes, and osteocytes from 
three different sites involved considerable cost and possible pain. Selecting an 
appropriate multipotent stem cell is easy for clinical operations.  
2.2.1 Multi-Potency of Bone Marrow Derived Stem Cell 
Messenchymel stem cell is an adult stem cell, which could be derived from two main 
sources. One is the bone marrow blood and the other is the adipose tissue. The bone 
marrow derived MSC have been proved the multipotency by much research work 
through the tri-lineage differentiation into the osteogenic, chondrogenic and 




Figure 2.7: Morphology of BMSC when cultivated in basal medium (hematoxyin 
staining, a), osteogenic medium (Alizarin Red staining, b), adipogenic medium (Oil 
Red O staining, c), and chondrogenic medium (Toluidine blue staining; d)[49] 
 
Recently much study has focused on the adipose derived MSC due to larger available 
source and easy handling. The adipose derived MSC does also show the multi-lineage 
differentiation capability [56-58] and some research even takes a comparative study 
of the cell proliferation as well as differentiation capability between the bone marrow 
derived MSC and adipose derived MSC[52, 59-61]. Cytochemical qualitative analysis 
and calcium mineralization in Figure 2.8 demonstrate higher levels toward osteogenic 
differentiation in B-MSCs than in AD-MSCs[59], which makes it more suitable for 
ligament to bone regeneration.  
At the same time, ADSC showes the batch variation, therefore being inconsistent in 





Figure 2.8: comparison of BMSC and ADSC capability for osteogenic differentaiton 
m cell for multi-lineage differentiation  [59] 
 
2.2.2 Bone Marrow Derived Stem Cell for Ligament Tissue Engineering 
The multipotency of BMSC makes them a good cell source for ligament tissue 
engineering. It has proven that mesenchymal stem cell could be differentiated into 
fibroblastic cells for ligament regeneration and have a better proliferation rate and 
collagen production than fibroblast [16-18].  
There are other studies reporting the great potential of BMSC for ligament tissue 
engineering. Teh et al [62] had studied the enhanced differentiation of BMSC on 
aligned hybrid silk scaffold.  The alignment of the silk fibroin electrospun nanofiber 
on the knitted silk microfiber was believed to provide the topographic cues for the 
positive cellular response, which allowed the BMSC to proliferate and differentiate 
into the oriented spindle-shaped morphology and produce an align ECM network, as 
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shown in Figure 2.9, quite similar to the morphology of  fibroblast cell and ECM 
distribution in the native ligament.  
 
Figure 2.9: Confocal micrograph illustrating actin fibers (red) and nuclei (blue) of 
fluorescent-stained MSCs seeded on (A, C, E) RD and (B, D, F) AL scaffolds, and 
cultured for (A, B) 3 days, (C, D) 7 days and (E, F) 14 days[62]. 
 
Besides, the mechanoactive stimulation, such as the uniaxial tension had proven to 
largely enhance the BMSC differentiation into tenogenesis in an engineering 3D 
construct [63]. A significant up-regulation of the tenogenic related gene marker was 
found in both native and synthetic 3D constructs seeded with BMSC under dynamic 
mechanical loading, as compared to the static culture [64-67], as shown in Figure 2.10. 




Figure 2.10 : Collagen I (A), collagen III (B), and tenascin-C (C), markers for 
tendon/ligament fibroblastic differentiation, were up-regulated in human marrow 
stromal cells encapsulated in constructs under cyclic tensile strain compared to static 
constructs by day 21[66]  
 
Figure 2.11: Tensile stimulation increased linear stiffness[65] 
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The mechanism of tenogensis of BMSC on a dynamic, 3D cultured tissue engineering 
model was investigated by analyzing the effect of cyclic stretching on the matrix 
deposition and gene expression of marker gene in Kuo et al’s study[63]. It was found 
that the potential involvement of matrix remodelling and Wnt signalling was crucial 
for enhanced tenogenesis of BMSC in a mechanoactive environment. 
2.2.3 MSC-Based Therapy for Osteo-integratoin of Ligament Graft 
Besides the great potential of BMSC in ligament tissue engineering, the BMSC-based 
therapy was also applied in direct ligament graft implantation. The main problem with 
the ligament graft implantation is lack of the osteointergration with the bone tunnels 
which are created during the implantation process. In chapter 1, it was already 
discussed using the calcium phosphates or periosterium wrap to enhance the 
biological fixation of the graft. Some other methods are focused on the growth factor 
delivery, such as incorporating the BMP2-loaded collagen I into the bony ends of the 
graft [68] as well as gene therapy of transferring BMP2 gene for enhancing bone to 
tendon healing[69]. 
Some research investigates the bone marrow derived messenchymal stem cell delivery 
on improving the osteo-intergration of the ligament graft. Lim et al[70] studied the 
enhancement of BMSC loaded in fibrin glue on the osteointergration of hamstring 
tendon autograft. The control group without the BMSC only showed the fibrous tissue 
like the Sharpey’s fiber around the tendon-bone interface at week 8. However, in 
experiment group with BMSC, the cartilage cells appeared as early as 2
nd
 week after 
the surgery, as shown in Figure 2.12. Furthermore, a mature cartilage zone where 
collagen type II was heavily stained was observed gradually blending from the bone 
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to tendon graft by week 8, similar to the histology characteristics of the native tendon 
to bone insertion.  
 
Figure 2.12: Observation of cartilage cell in 2-week BMSC- treated ligament graft[70] 
Soon et al also studied of the use of BMSC to enhance the tendon osteointergratoin of 
the Achilles tendon allografts. The BMSC was loaded in the same fibrin glue carrier 
in this study. The similar result of the fibrocartilage transition zone occurred at week 
8 in the experiment group as Lim did.  And the biomechanical testing results in Figure 
2.13 show that the MSC-enhanced grafts had significantly higher load-to-failure rates 
than controls[71].  
  





2.2.4 MSC for Ligament to Bone Insertion Regeneration 
Based on consideration of the transition zone structure of the tendon/ligament to bone 
insertion, the tissue engineering of the ligament to bone interface instead of ligament 
alone is emphasized and tried in several studies. BMSC is selected as a good cell 
source for this interface tissue engineering due to the great multipotency and 
controllable differentiation.  
He et al studied the chondrogenesis of BMSC under co-culture of fibroblast and 
osteoblast for the fibrocartilagous interface regeneration on a tri-phasic hybrid silk 
scaffold, and it was found that the endogenous signal released from the differentiated 
cell lines did simulate the BMSC differentiating into the fibrocartilag-like tissue. 
Furthermore, the BMSC co-cultured with osteoblast on hydroxylapatite coated silk  
phase was differentiated into calcified fibrocartilage, while the BMSC co-cultured 
with fibroblast turned into the fibrocartilage only, without being mineralized[72].  
In Ma[73] study, the BMSC was used as the only cell source for 3D bone-ligament-
bone constructs development. The BMSC was isolated and then proliferated and 
differentiated into bone-like and ligament-like cells using the growth medium and 
induced factors. Then the bone and ligament monolayer were collected when they got 
confluent on normal culture dish and then transferred to Sylgard-coated dishes. The 
3D bone construct was formed with two minutien pins placed on the monolayer about 
20mm apart to each other. Furthermore, two of 3D bone constructs were in line 
axially pinned on top of the ligament monolayer which was transferred on Sylgard-
coated dish, finally forming an 80mm long bone-ligament-bone construct. The 




Figure 2.14: Fabrication process of a BLB construct in vitro [73] 
The construct was implanted in sheep model and then underwent 6 month in vivo 
regeneration. The results showed a well-organized structure, with native bone 
integration, a functional enthesis, vascularization, innervations, increased collagen 
production and structural alignment. And the biomechanical performance of this 
construct after 6 month in vivo culture was comparable to that of the native ACL, 






2.3  Silk Based Scaffolds 
Silk from silkworm bombyx mori has proven to be biocompatibable after removing 
outside layer of the sericin. Therefore, it is widely used in biomedical application, 
especially as scaffold material for tissue engineering due to the robust mechanical 
properties.  
It has already discussed in chapter 1 that silk material was successfully applied in 
ligament tissue engineering, either in the form of braided 3D structure or the knitted 
form with the sponge deposited in the openings[26, 27]. The in vivo implantation of 
the silk ligament graft in animal model further proved their good biocompatibility as 
well as the superior mechanical properties[28, 29].  
2.3.1 Biochemistry of Silk Fibroin 
Given that the silk had good biocompatibility as well the robust mechanical properties, 
understanding their biochemistry helps make it sense for their superiority as good 
candidate as biomaterials for tissue engineering.  
Silk is generally defined as protein polymers, which are produced within specialized 
glands. It could be from different sources, such as silkworm, spider or other flies. 
Their composition, structure as well as the properties is varied dependent on specific 
source.  Similar to collagen, silk is also a fibrous protein which had a highly repetitive 
primary sequence, therefore having a significant homogeneity in secondary structure, 
like the beta-sheet structure[74]. That may explain the impressive mechanical 
properties of the silks.  
Silk from silkworm, bombyx mori contained two components, the outsider layer of 
sericin, a glue-like protein and the inner protein of fibroin, which could be further 
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divided into two chains, a heavy chain with mass of 325kDa and a light chain with 
mass of 25kDa[74]. And based on conformational energy analysis, the amino acid 
sequence of the silk fibroin heavy chain is defined as a model of (Ala-Gly)n 
polypeptide repeat[75].  
2.3.2 Silk Fibroin Based Biomaterials for Ligament Tissue Engineering. 
As we discussed above, the biocompatibility of the silk depended on complete 
removal of the sericin protein, leaving silk fibroin protein only. There is already much 
reported literature on the protocol of removing the sericin from the fibroin. Normally 
the sericin is removed by boiling in alkaline solution. In more details, the silk is 
boiled in 0.1% of sodium carbonate solution at temperature of 98°C to 100°C for 
about half an hour under magenetic agitation and repeated thrice until complete 
removal of secrine[18, 27].  Tel et al [76]studied the optimal condition for sericin 
removal for maintaining the structure and mechanical properties of silk fibroin, which 
indicated that  degumming the knitted scaffold at 100°C for 30 min under agitation 
gave the negligible mechanical and structure degradation for the silk fibroin. 
The silk fibroin based scaffold have been used widely in the ligament tissue 
engineering due to the remarkable mechanical properties and slow degradation, which 
meets the slow healing rate of ligament and therefore provides the robust mechanical 
support during the process. However, the silk fiber itself, either in the knitted form or 
braided or woven form is not optimal for cell seeding and proliferation due to the 
large pore size between each single fiber. Therefore, the hybrid silk fibroin scaffold 
was developed by lyophilizing the silk fibroin solution which was pouring into the 
openings of the knitted silk fiber. A piece of silk sponge embedded in the knitted silk 
fiber mesh was formed which not only favoured the cell spreading and attachment, 
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but also maintained the strong elastic properties arising from the knitted silk fiber. 
This hybrid scaffold was made and tested by a series of in vitro and in vivo study and 
had a satisfactory performance both in increased the cell proliferation rate and extra 
cellular matrix deposition[18, 27-29]. Besides, the silk fibroin could be blended with 
other natural polymer, such as collagen and gelatine, which mimicked the native 
component of ECM, therefore allowing better cellular interaction[77, 78].  
2.3.3 Silk Fibroin Based Biomaterials for Ligament to Bone Insertion 
It was described in Liu’s paper that there was indication that bone mineralization was 
lack off in both tibia and femur tunnels when micro-CT scanning was done. Neither 
there was lack of transitional zone region of fibrocartilage between the ligament and 
bone when the histology staining was done. These two insufficiencies make the 
regenerated ACL intergration poor, therefore unable to fully restore the function of 
native ACL. Based on this, the homogenous silk fibroin based ligament graft alone 
was concluded not optimal for functional ACL regeneration, due to lack of support for 
formation of the ligament to bone insertion.  
He et al modified the silk fibroin graft with hydroxyapatites coating in the ends by 
novel alternative soaking methods and proved the both osteoinductivity and 
osteoconductivity in vitro[79]. Later it was further studied the in vitro bone-ligament 
regeneration using a trilineage co-culture system on this modified scaffolds[72]. 
Shi et al implanted the calcium phosphate coated silk graft into the New Zealand 
white rabbits for ACL reconstruction, and the bone tunnel mineralization was more 
obvious  than the negative control group, proved by both the micro-CT scanning and 
histological staining[80].  
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2.4   Biological Factors  
2.4.1 Growth Factor for BMSC Differentiation 
It is proved that the bone marrow derived stem cell has multi-lineage differentiation 
potency, and the induction of differentiation into certain lineage could be controlled 
through multiple factors, either the mechanical stimulus or the biological factors. 
Growth factor, such as the family of the transforming growth factor-β, has been 
delivered either in vitro or in vivo for BMSC proliferation and differentiation.  
Growth factor mainly functions as a ligand for recognizing the receptor on the cell 
surface, then further inducing a cascade of cellular activities, such as activating the 
Smad gene expression, therefore controlling the differentiation of the precursor cells.  
It is widely studied that the bone morphogenic protens (BMP) are osteo-inductive 
growth factor, therefore enhancing the osteogenesis of BMSC. It is further proved that 
among all the BMP proteins, BMP2 was most osteo-inductive. The in vitro 2D or 3D 
study of BMP2 effect on BMSC is well documented. Furthermore, BMP2 is delivered 
through different vehicles for the bone healing for in vivo study or clinical trials. 
However, recently the research showed that the high dose of BMP2 was toxic and was 
even carcinogenic. Therefore delivering the appropriate dosage of BMP2 is crucial for 
clinical usage.   
The transforming growth factor β is another big family of growth factors, which 
functions by binding with the receptor in the cell trans-membrane. Among this family, 
TGF-β1 and TGF-β3 are widely used for inducing chondrogenesis of BMSC. And 
some research shows the synergetic effect of TGF-β 1 or 3 with other growth factor 
on the chondrogenesis of messechymal stem cell, such as the BMP6.  
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The fibroblastic growth factor family, short as FGF is investigated to enhance the 
epithelial cell proliferation and is therefore widely used for the skin wound healing. 
Recently, people found its effect on tenogeneis by enhancing the differentiation of 
BMSC into the fibroblastic cells. The basic FGF was delivered effectively by either 
the nanofibers or microspheres for the fibroblastic differentiation in many studies 
although having the short half-life.  
2.4.2 Biomaterials Based Delivery Vehicles for Growth Factor 
Since most of the growth factor is unstable in solution form due to the short half-lives 
and was very expensive even in small amounts, the effective way to deliver the 
growth factor is crucial for appropriate usage. There are several general requirements 
for an ideal growth delivery system [81] 
1. High biocompatibility  
2. Low immunogenicity and antigenicity 
3. Good affinity  
4. Maintenance and enhancement of bioactivity 
5. Predictable biodegradability 
6.  Controlled and tailored protein release at an effective dose for the appropriate 
period of time according to defect  anatomical site, size and vascularity 
7. Safety, stability, sterility, availability and cost-effectiveness. 
But in reality, there is no ideal system which could meet all the requirements. The 
natural biomaterials based vehicles are more preferred due to the good biocompability 
as compared to inorganic materials and least harsh way of fabrication, therefore being 
able to maintain the bioactivity of growth factor. Furthermore, their degradability is 
controllable by changing the cross-linking concentration or the molecular weight, 
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which leads to the controlled profile for sustainable release. Among the biomaterials 
based vehicles, two morphologies are very commonly used in tissue engineering, 
which are microspheres and sponge scaffolds 
2.4.2.1 Microspheres Based Carriers 
The microspheres delivery systems have the advantage of high surface to volume ratio, 
therefore having more surface area to binding to the growth factor. Also they could be 
tailored and controlled to have desired growth factor release kinetics. There are many 
reported successful microspheres delivery systems for tissue engineering and BMSC 
differentiation. 
Gelatin microspheres 
Gelatin is a denatured collagen; therefore it is a protein by nature. They have two types 
of gelatin powder based on different processing methods. Gelatin isolated from acidic 
processing is called type A or acidic gelatin, which has an isoelectric point (IEP) of 
about 9, therefore carrying the net positive charge at a physiological pH of 7.4. In 
contrast, gelatin isolated from an alkaline process is basic gelatin or type B gelatin and 
has IEP around 5, and carries the net negative charges at physiological pH[82]. 
Therefore, the charged moieties on the gelatin make them have good affinity with the 
charged proteins via electrostatic forces or polyionic complexing. By changing the 
type of the gelatin and pH of the solution, the release kinetics of the growth factor 
could be controlled.  
The gelatin microspheres are usually made by water- in- oil emulsion method. After 
the emulsion is formed, the gelatin is allowed to solidify below 37°C and cross-linked 
by gluatarldyde or genipin to non-soluble networks, making it suitable for long term 
release of growth factor [83]. The cross-linked gelatin microspheres wouldn’t undergo 
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hydrolysis, but it still could be enzymatic degraded by either in vitro introducing the 
collagenase IA which can digest the gelatin by recognizing the –Pro–X–Gly–Pro
– sequence [84] or by in vivo cellular action which breaks down the gelatin through 
the secretion of specific matrix metalloproteinases[82].This enzymatic degradation is 
also affected by the cross-linking degree[85] , meaning that the release kinetics can be 
controlled by the cross-linking agent concentration.  
In the work of Zarana S. Patel [84] et al, it investigated the release kinetics of the 
BMP2 from the biodegradable gelatin microspheres by controlling all the different 
parameters, such as the concentration of the cross-linking agent glutarldehyde, the 
type of gelatin used, the release buffer containing collagenase. And most of the 
release kinetics exhibited minimal burst release and sustained release up to 28 days, as 
shown in the Figure 2.15. Therefore, this sustained release profile of BMP2 from the 
gelatin microspheres made it competent as the BMP2 carrier for the bone healing and 
bone tissue engineering. 
Alginate microspheres 
Alginate is polysaccharide found abundantly in the surface of seaweeds [81]. Due to 
non-immunogenic properties, alginate is also widely used for micro-encapsulation of 
growth factor protein in tissue engineering.  The alginate microspheres are usually 
made by gelation of the sodium alginate solution in the calcium chloride and carry the 
same net negative charge as BMP2. Therefore, the loading of the BMP2 into the 
alginate microsphere is usually done by coating of polycation membrane, such as 
poly-L-lysine. But, most of the reported release kinetics of BMP2 from the alginate 
microspheres are not enough sustainable for 1 month and have high burst release , 
although it showes that increasing the viscosity of the alginate solution slowed down 
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the release rate[86]. Besides, the biocompatibility of the alginate-polycation 
microcapsules still remaines variable since the polycation such as PLL may cause 
immunogenicity[87] 
 
Figure 2.15: In vitro release of BMP-2 from acidic and basic gelatin microparticles. 
From acidic gelatinin (a) PBS and (b) collagenase-containing PBS, and from basic 
gelatin microparticles in (c) PBS and (d) collagenase-containing [84] 
 
2.4.2.2  Sponge Scaffolds as Growth Factor Delivery Carriers 
Delivery of growth factor into the sponge scaffold is also common and more direct for 
tissue engineering. However, they have the problem of retarding the bone growth 
factor at the defected size since the growth factors isloaded and released mostly 
through the diffusion of the solvent or swelling of the sponge scaffold.[88] Two 
common nature biomaterials based sponge scaffolds are collagen and silk fibroin. 
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Collagen sponge  
Collagen sponge is currently the only FDA approved delivery system of bone 
morphogenetic proteins for clinical use due to their high biocompatibility [89] since 
collagen is the component of native extracellular matrix in the body. And there are 
many reported successful clinical trials, such as delivery the BMP2 for ectopic bone 
formation by implanting the BMP2 loaded absorbable collagen sponge into the 
defected site. However, the collagen sponge still have inferior properties, such as the 
xenogenic nature of the collagen (mostly bovine and porcine skin)[81] and poor 
mechanical stability. 
Silk fibroin sponge 
Silk fibroin is the degummed silkworm silk by removing the glue-like sericine so that 
it wouldn’t cause the immunogenicity. Both the in vitro and in vivo delivery of the 
growth factor using the silk fibroin sponge or matrix have been reported [90, 91] 
The David L. Kaplan group had shown that the 3D silk fibroin loaded with BMP2 
could induce the osteogenic differentiation of human bone marrow stromal cells in 
vitro and bone tissue formation in vivo [90] . However, the in vitro release profile 
showed that the silk fibroin can only retain the 75% of BMP2 for only 1 week, as 




Figure 2.16: Retention of BMP2 in the 3D silk fibroin sponge [90] 
2.4.2.3 The Composite Scaffold with Growth Factor Loaded Microspheres 
Since the sponge scaffold itself doesn’t have retarded and controlled release kinetics 
for the growth factor delivery, recently many works tried to incorporate the growth 
factor loaded microspheres inside the scaffold to form the composites scaffold to 
realize the sustained delivery of growth factor for tissue healing or tissue engineering 
[92-95]. 
In X.F Liu’s work, thermally induced phase separation method was applied to 
fabricate the porous poly-lactic acid/chitosan microspheres (PLA/CMs) composites 
which contained different quantities of chitosan microspheres. And the composites 
not only have improved release kinetics but also have better compressive modulus[92].  
Besides, Shi et al had demonstrated that the BMP2 loaded microspheres 
chitosan/collagen composites were more effective to induce implant osseo-integration 
in dogs than the chitosan/collagen scaffold only due to the sustained release of BMP2 
from the composites [93].  
Esther Wenk, et al, successfully prepared silk fibroin scaffolds embedding insulin 
growth factor I (IGF-I) loaded PLGA microparticles within interconnective pores via 
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a porogen leaching protocol. And the composite silk fibroin scaffolds also proved to 
have more sustained release kinetics[94]. 
2.4.3 Growth Factor Gradient Development for Interface Tissue Engineering 
Since growth factor is a good biological stimulus for BMSC differentiation and tissue 
engineering, people start to develop growth factor gradient delivering system for 
interfacial tissue engineering, such as the osteochondrol tissue engineering.  
Many studies have focused on microspheres-based growth factor gradient 
development. Different growth factor encapsulated microspheres was sintered in a 
custom-made programmable way to form scaffolds with gradient in growth factor 
concentration.  Nathan et al [96]fabricated gradient scaffolds with spatial patterning of 
different biological cues loaded PLGA microspheres, of top were osteogenic cues 
BMP2 and of bottom are chondrogenic cues TGF-β1 as shown in the schematic 
Figure 2.17 and the gradient was formed using two different programmable syringe 




Figure 2.17: Sectioning and orientation of the gradient scaffold construct[96] 
 
Figure 2.18:  Programmable pumps created a gradient in microsphere types based on a 
time-dependent process[96] 
 
This gradient scaffold was then seeded with stem cells in order to form osteochondrol 
interface. Both histology and gene results showed better differentiation in gradient 
scaffold than blank control.  
David Kaplan Group haD also made silk fibroin scaffolds with reverse gradient of 
two different growth factors of BMP2 and rhIGF-1 loaded in silk microspheres for 
osteochondral tissue engineering using a similar method. And the ELISA kit 
quantified the concentration of each growth factor in each segment of the cylindrical 
scaffold which was cut into 7 pieces along the longitudinal length. And linear 
concentration was plotted along the scaffold longitudinal length, proving the 
successful formation of linear bioactive factors gradients in the scaffold [97], as 




Figure2.19: Growth factor gradient in silk microspheres incorporated silk scaffolds[97] 
 
And the gene expression of both MSC expressed chondrogenic and osteogenic  
markers showed corresponding gradient relationship along the gradient growth factor 
concentration, which indicated the scaffolds with growth factor gradients did have 
positive effects on the osteochondral differentiation, as shown in Figure 2.20.  
 
Figure2.20: hMSC osteochondral differentiation in growth factor-gradient silk 
scaffolds.[97] 
 
Besides, Lee et al[98] fabricated a three dimensional porous matrix scaffold with 
growth factor gradient by surface immobilization of the growth factor BMP7, TGF-β2, 
VEGF165 to heparin conjugated PCL pre-scaffold which has surface area gradient 
formed already by centrifugation.  And both fluorescence microscopy imaging and 
ELISA method showed the gradients of growth factor formation along the 
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longitudinal axis of the cylindrical scaffolds, as shown in Figure2.21. And it was 
stated that this scaffold would have potential for a variety tissue formation, such as 
bone-cartilage junctional tissue by controlling the growth factor gradients.  
           
Figure2.21: Growth factor gradient formation along the longitudinal axis of 
cylindrical scaffolds [98] 
 
But currently the bioactive cues gradient scaffold was only applicable to osteochondral 
interface since there was a common osteochondral medium, which could make BMSC 
differentiate into both osteogenic and chondrogenic lineage. It was still difficult to 
apply this idea to fibrocartilaginous enthesis which involved three different tissues and 




Chapter 3 Investigation of the Appropriateness of BMSC as Single 
Cell Source for in vitro Bone-Ligament Interface Regeneration via 
2D Tri-Lineage Study 
 
3.1 Introduction 
Bone marrow derived stem cell was massively investigated in previous research to 
prove its multi-potency of differentiation through 2D studies. However, majority of 
these studies were focused on osteogenesis, chondrogenesis and adipogenesis.  In this 
study, BMSC was going to be used as the single cell source for in vitro bone-ligament 
(B-L) binterface regeneration, which required BMSC to be able to differentiate into 
the bone, fibrocartilage as well as ligament. Therefore, it was still necessary to 
investigate multiple differentiation of BMSC in terms of these three specific lineages 
for B-L interface regeneration. Moreover, this chapter also tried to find the 
appropriate culture medium for co-culture study in later stage and investigate the 





3.2 Methods and Materials 
3.2.1  Harvest and Culture of Porcine Bone Marrow Derived Stem Cell 
The BMSC used in this project was not commercially purchased, but rather harvested 
from the porcine bone marrow blood, which was extracted in the anatomical site of 
porcine iliac crest. The bone marrow blood was plated in the T175cm
2
 culture flask, 
mixed with the culture medium made up of Gibco® Low Glucose Dulbecco’s 
Modified Eagle Medium with GlutaMax, 15% Fetal Bovine Serum (FBS) and 1% 
Penicillin/Strep (P/S), in a volumetric ratio of 1:2. Then the mixture of blood and 
medium was placed in 37°C incubator for 1 week before removing all the blood.  
Multiple colonies-forming units (CFU) were detected on the bottom surface of the 
flask after removing the blood.  These CFU were considered as the primary porcine 
BMSC, and further subculture were done by following series of steps, which were 
removing the culture medium, washing the flask with the same amount of sterilized 
1XPhosphate Buffer Solution (PBS),  tripsinizing the adherent cell monolayer with 
10ml of Triple Express at 37°C incubator for about 5-10 min, termination of  the 
tripsin activity by adding another 10ml of fresh culture medium, and finally collection 
of the cell suspension into 50ml Falcon tube, centrifugation of the cell suspension at 
1500rpm for 5 min, removing the supernatant, suspension of the cell pellet with new 
fresh medium, then transferring into new flasks at density of 50,000cell/ml and 
culturing at 37°C incubator again. All BMSC was sub-cultured to passage 3 before 
starting the differentiation study in this project.   
 Otherwise, the cell can be cryopreserved by following the same procedures as 
subculture except the different last step which are suspension of the cell pellet using 
freezing medium made of LG- DMEM, FBS, dimethylsulfoxide (DMSO) in a 
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volumeric ratio of 7:2:1, collecting 1-2ml of the cell suspension into 2ml labelled 
cryovials in density of 1millon/ml, transferring all the cryovials into Iso Pproplye 
Alcohol (IPA) containing cryobox and stored at -80°C freezer overnight before 
storing at liquid nitrogen tank. 
3.2.2 Conducting the 2D Tri-lineage Differentiation  
For the tri-lineage differentiation of BMSC, five different culture medium were 
prepared, three of which were conventionally induced medium for osteongesis, 
chondrogenesis, ligamenesis and the other two were normal proliferation medium and  
mixed medium based on these three induced medium in volume ratio of 1:1:1. The 
components for each medium were summarized in the Table 3.1. The reason of 
adding the other two medium besides of the conventionally induced medium is to 
investigate the impact of medium on the differentiation besides the growth factor. 
 
The overall culture period for each lineage was all three weeks. But different growth 
factors were supplemented and two different dosages (considered as high/low) of each 
growth factor were also introduced. The summary of each study group was given in 
Table 3.2.  
 
To quantify the differentiation of each lineage, both genotype and phenotype results 
were analyzed after 3 weeks’ differentiation. For genotype results, total RNA was 
extracted from cell monolayer in each well plate (n=3). RNA extraction started with 
adding 1ml of Trizol into each well plate for cell lysis and RNA exposure, then 
followed by centrifugation of the collected cell lysate in 2ml microtube at 14000rpm 
for 5 min at 4°C and then transferring the supernatant in another new centrifuge tube, 
which was further added with 200 µl chloroform (avoid vortexing) and went for 15 
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min centrifugation at 13000rpm at 4°C. The first layer of supernatant was further 
collected into new tube and mixed with 600 µl of 70% diulted analytic reagent grade 
ethanol. The mixture was added by two times into the pink spin column provided in 
Qiagen RNeasy Kit (Qiagen, Valencia, CA, USA) and went for fast centrifugation at 
1000rpm for 15s and flow through was discarded. The column membrane was then 
washed by 700 µl RW1 buffer (diluted by 100%  high grade ethanol for 5 times) and 
500 µl RPE buffer next (both buffer provided by the kit) and each buffer was fast 
centrifuged and then discarded.  Finally the washed spin column was centrifuged at 
full speed for 1 min to remove the residual buffer and 40 µl of Rnase free water was 
added onto the membrane and the collecting tube was changed with new one and went 
for centrifugation at 1000rpm for 1min to collect the RNA solution in the tube. Once 
the RNA solution in water was collected, it was transferred on top of the ice and then 
the RNA concentration was measured using the NanoDrop machine (ND-1000 
Spectrophotometer, Biofrontier),  
 
After quantifying the RNA concentration, corresponding volume of RNA solution 
was calculated based on total 200ng RNA and mixed with 4 µl of iScript buffer(Bio-
Rad, USA), 1 µl  RT-nase and remaining volume of RN-ase free water for c-DNA 
replication through reverse-transcription using the thermo cycler 2720(Applied 
Systems, USA), which produced 20 µl c-DNA solution at a final concentration of 10 
µg/ml. Real time PCR quantification of  differentiation gene markers was further 
taken by mixing 12.5µl SYBR Buffer (Bio-Rad, USA) with 3.5 µl RNase free water, 
4µl cDNA solution (diluted to 2.5ng/µl after synthesis) and 5µl primer 
solutions( mixed forward and rear primer solution at concentration of 1µM) in iCycler 
iQ5 system (Bio-Rad, Laboratories, CA) with glyceraldehyde 3-phosphate 
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dehydrogenase (GAPDH) as reference gene.  Both forward and rear primer sequences 
of each gene were designed from porcine gene sequences obtained from NCBI 
GeneBank, using Primer 3 software and then verified by BLAST. And the primer 
sequences for each lineage gene markers are listed in Table 3.3. The amplification 
was performed in triplicates and the data was analyzed in relative expression using 
ΔΔCT method and normalized to expression level of housekeep gene GADPH.  
 
Table 3.1: Components listed in each culture medium for 2D Tri-lineage Study 
Group Culture medium Component of each medium 
1 Proliferative medium High Glucose Hyclone MEM +10% FBS+ 1% P/S 
2 Osteogenic Medium 
High Glucose DMEM+ 10% FBS +1% P/S+ 50 μg/ml 
ascorbic acid +10mM β-glycerphosphate+ 100nM 
Dexamethasone 
3 Chondrogenic Medium 
High Glucose Medium + 1X (ITS+ Premix)+ 50 μg/ml 
ascorbic acid +1X sodium pyruvate + 0.4 mM proline 
+1% P/S+100nM Dexamethasone 
4 
FibroblasticMedium 
(excluding the bFGF) 
High Glucose Hyclone MEM +10% FBS+ 1% P/S 





Table3.2: Summary of Groups of Different Combinations of Medium and Growth 
Factor Concentration for Each Lineage in 2D Study 
Lineage  Induced medium 
Concentration of 
growth factor 







1. 20ng/ml BMP2; 
proliferative medium 
2. 40ng/ml BMP2; 
proliferative medium 
Osteogenic medium 
3. 20ng/ml BMP2; 
osteogenic  medium 
4. 40ng/ml BMP2; 
osteogenic medium 
Mixture medium  
5. 20ng/ml BMP2; 
mixture medium 








1. 10ng/ml TGF-β3; 
proliferative medium 
2. 20ng/ml TGF-β3; 
proliferative medium 
Chondrogenic medium 
3. 10ng/ml TGF-β3; 
chondrogenic medium 
4. 20ng/ml TGF-β3; 
chondrogenic medium 
Mixture medium 
5. 10ng/ml TGF-β3; 
 mixture  medium 
6. 20ng/ml TGF-β3;  







1. 25ng/ml bFGF;  
proliferative medium 
2. 50ng/ml bFGF;  
proliferative medium 
Mixture medium 
3. 25ng/ml bFGF; 
 mixture medium 






Table 3.3: Primer Sequences for each lineage differentiation 
Osteogenic Genes Sequence 
Col I F: GTG GAT ACG CGG ACT TTG TT 
R: CCT GGG ATA CCA TCA TCA CC 
RunX2 F: GAG GAA CCG TTT CAG CTT ACT G 
R: CGT TAA CCA ATG GCA CGA G 
ALP F: ATG AGC TCA ACC GGA ACA A 
R: GTG CCC ATG GTC AAT CCT 
OC F: TCA ACC CCG ACT GCG ACG AG 
R: TTG GAG CAG CTG GGA TGA TGG 
Chondrogenic Genes Sequence 
Col II F: ATC TGG CTT CCA GGG ACT TC 
R: AAT ACC AGC AGC TCC CCT CT 
Agg F: TCA GGA GTT CTT TCT GGC GT 
R: CAA ACT GGT GTC CAC GAA TG 
SOX9 F: GTT CGA GCA AGA ATA AGC CG 
R: GAG TTT GCC CAG AGT CTT GC 
Tenogenic Genes Sequence 
Col I F: GTG GAT ACG CGG ACT TTG TT 
R: CCT GGG ATA CCA TCA TCA CC 
Col III F: TTT GTC CAC AAC CTC CAA CA 
R: CCT GCT ACT CCA GCC TTG AC 
Ten C R: AGA AAC CGT AAA CCT GGC CT 
F: CCA GTA TTG CAA ACA CAC GG 
Housekeep Gene Sequence 
GADPH F: CCA GAA CATCAT CCC TGC TT 





3.2.2.1 2D Osteogenic Differentiation under Induction of BMP2  
For 2D osteogenic differentiation, 10,000 P3 BMSC was seeded in 12 well plates and 
cultured with normal proliferation medium for 3 days to allow for monolayer 
confluence. Then the culture medium were replaced with three fresh different culture 
medium and added with fresh 2 µl or 4 μl of 10 µg/ml BMP2 solution, which was 
finally diluted by the medium to 20ng/ml or 40ng/ml. Both medium and growth factor 
was refreshed every three days until to 3 weeks. 
Besides of the RNA quantification for genotype results, alizarin red staining was done 
to qualify the deposition of calcium in the extracellular matrix in the cell monolayer in 
culture plate. The alizarin red dye solution was prepared with dissolving 0.2g of 
Alizarin Red powder into 10ml of distilled water and filtered. The pH value was 
adjusted by slowing adding 1M of NaOH solution and measured by pH-meter until 
reaching a final pH between 4.1-4.3. In the meanwhile, the culture medium was 
removed and cell monolayer was washed twice with 1XPBS before fixation the ECM 
with pre-cooled methanol and incubated at -20°C for 5 min. 2ml of pH adjusted dye 
solution was then pipetted into well plate after removing the methanol and washing 
with distill water twice. The reaction of the dye solution with the calcium ions in the 
cell monolayer only need 30s at room temperature and the red staining spot was 
detected after removing the dye solution and washing with 1XPBS twice.   
3.2.2.2 2D Chondrogenic Differentiation under Induction of TGF-Β3 
In 2D chondrogenic differentiation, the cell culture was different from the well plate 
culture for osteogenesis. Since it was shown that BMSC can only be induced to 
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chondrocytes when they were condensed, therefore BMSC cell pellet was cultured in 
15ml of Falcon tube with 1ml of culture medium instead of monolayer cultured in 
well plate and was formed by centrifugation 300,000 p3 BMSC after harvest from 
confluence p2 cell monolayer in T175cm
2
 culture flask. Three different culture 
medium were directly added into different study groups. Fresh 1 µg/ml TGF-β3 
solution was prepared by reconstitution of one vial of 10µg sterile lyophlized TGF-β3 
powder (ImmunoTools, Germany) with 10ml of sterile 4mM HCl solution containing 
0.1% BSA and then 10 µl or 20µl TGF-β3 solution was added into the culture 
medium to form diluted concentration of 10ng/ml or 20ng/ml for induction of 
differentiation. The total culture period and medium and growth factor refresh 
frequency was the same as osteogensis.  
Instead of Alizarin Red staining for detection of calcium ions to prove the existence of 
osteogenesis, Alcian blue staining was done to detect the glycoaminoglycans(GAG), 
which is an important indicator for chondrogenesis. Before the staining, the cell pellet 
was collected after 3 weeks of differentiation induction and fixed by 10% formalin 
overnight. Then the cell pellet was embedded into tissue freezing medium(Cryomatrix, 
Thermo Scientific) which was liquid at room temperature but solidified at -20°C and 
then cut into slice of 10µm thickness using Cryostat machine (Leica, USA) onto the 
positive charged silicon slides. The alcian blue dye was prepared by dissolving 0.1g 
of Alcian dye into 9ml of distilled water and 1ml of 1N hydrochloric acid to form a 
final pH at 1.0. At the same time, the nuclear fast red to counter stain the cell nuclear 
was prepared by dissolving 0.01g of nuclear fast red power into 5% (w/v) ammonia 
sulfate solution and slowly heat the solution to allow fast dissolving. The pellet cut 
slice was rinsed by the distilled water at room temperature to remove the freezing 
medium first and then incubated with the alcian blue solution for 30 min to stain the 
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GAG, then followed by rinsing the slide with distilled water twice again and then 
incubated with the nuclear fast red solution for another 5 min to stain the cells and 
rinsing after that. The stained slide was then dehydrated by a gradient concentration of 
90%, 70%, 50%, 50% alcohol sequentially and then washed by 100% xylene solution 
and covered by the Depax mounting medium Glurr. 
3.2.2.3 2D Fibroblastic Differentiation under Induction of bFGF 
For 2D fibroblastic differentiation, it was cultured in the same way as osteogensis, 
except that the culture medium was only two groups since the normal proliferation 
medium was the same as the induced fibroblastic medium (when bFGF was excluded). 
And fresh 2.5 µg/ml of bFGF solution was prepared by reconstitution of 25 µg sterile 
lyophilized bFGF powder (ImmunoTools, Germany) into 10ml autoclaved 1XPBS 
solution with 0.1% BSA.  Then 10µl or 20µl solution was added into the 1ml culture 
medium to form a diluted concentration of 25ng/ml or 50ng/ml for differentiation 
induction, which last for three weeks also with medium change and growth factor 
refreshed every three days. Four different combination groups were studied to analyze 
both gene results and specialized ECM protein characterization.  
Different from direct staining for osteogenesis and chondrogeneis charecterization, 
immunofluorescence antibody staining of specialized fibroblastic ECM protein was 
done in order to characterize Collagen type I (Col I), Collagen type III (Col III), 
Tenascin C(TenC), which are not only gene markers but also protein markers for 
tenogenesis. Both primary antibody and secondary antibody with DAPI solution were 
prepared for this staining. Col I primary antibody solution was prepared by diluting 
the original mouse anti-mouse Collagen I monoclonal antibody solution (Sigma, USA) 
by factor 1000, while Col III and TenC was diluted by a factor 200 of original mouse 
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anti-human Collagen Type III or mouse anti-human TenascinC monoclonal antibody 
solution  (Millipore, USA). While the second antibody solution was prepared by 
diluting the Goat anti Mouse Alexa Fluor 488 (Invitrogen, USA) solution by factor 
400 with DAPI (Invitrogen, USA) solution diluted with factor 800.  
The cell monolayer in the well plate was fixed by pre-cooled methanol at -20°C for 10 
min first, same as done in osteogenesis and then incubated by 1XPBS with 3% BSA 
solution for 30 min to block the sample. After that, incubate the cell sample with 
corresponding primary antiboby solution for 90 min at room temperature first, then 
remove the solution and incubate with PBS buffer containing 0.05% Tween 
20(Sigma-Aldrich, USA) for washing. Fluorescent secondary antibody solution was 
then added and incubated for another 30 min at room temperature and in darkness to 
avoid fluorescence bleaching, followed by washing and incubation with PBS buffer 
containing 0.05% Tween 20 for 20 min again. Once the staining done, the cell sample 
was visualized using fluorescent imaging microscopy (Olympus IX71, Japan) image 
analysis software (MicroImagev4.5.1, Olympus, Japan). 
3.2.3 Statistical analysis 
Statistical analysis was taken for gene expression results. All data were expressed as 
mean ±standard derivation (SD). Significance analysis was performed by pairwise 
comparison of experimental groups (n=3) using two-tailed, unpaired student T-test, 




3.3.1 Morphology of Undifferentiated P0 BMSC and P3 BMSC  
 
Figure3.1: Microscopy images of P0 BMSC (A) and P3 BMSC (B) 
Figure 3.1 shows the morphology of the primary BMSC (P0) that was colonized after 
removing the blood. The individual cell morphology looked like spindle structure. 
The P3 BMSC kept the similar morphology as P0 BMSC, indicating that there was no 
change of cell phenotype. 
3.3.2 2D Tri-lineage Differentiation Results 
3.3.2.1 2D Osteogenic Lineage 
A. Morphology of Differentiated P3 BMSC in Osteogeneic Lineage 
 
Figure3.2: Microscopy images of P3 BMSC cultured with 20ng/ml BMP2 in 




As seen in Figure 3.2, the images A&C show more elongated cell morphology than B, 
where the cells looked like round shape and there were some areas with dark 
deposition.  
B. Alizarin Red Staining of Differentiated P3 BMSC 
 
Figure 3.3: Alizarin red staining of P3 BMSC induced in different combinations of 
culture medium and growth factor concentration after 3 weeks culture: proliferative 
medium with 20ng/ml BMP2 (A) and 40ng/ml BMP2 (D); osteogenic medium with 
20ng/ml BMP2 (B) and 40ng/ml BMP2 (E); mixed medium with 20ng/ml BMP2 (C) 
and 40ng/ml BMP2 (F) 
 
From the Alizarin red staining results shown in Figure 3.3, it can only see red calcium 
staining in groups B&E, which were cell groups cultured in conventionally osteogenic 
induced medium. Furthermore, group E with higher dosage of BMP2 concentration 





C. Expression of Osteogenic Lineage Gene Markers  
Figure3.4: Expression results of osteogenic differentiation gene markers: Col I (A), 
RUNX2 (B) and ALP (C) 
The gene expression results in Figure 3.4 show the up-regulation of all three 
osteogenic gene markers Col I, ALP, RUNX2 in osteogenic medium group with 
40ng/ml BMP2 compared to all other groups, which was consistent with the Alizarin 
Red staining. The expression of Col I & ALP gene markers were also up-regulated in 
two mixed medium groups as compared to the other three groups (except the 
osteogenic medium group with 40ng/ml BMP2). However, in two normal 
proliferative medium groups and osteogenic medium groups with 20ng/ml of BMP2, 
all three gene markers were down-regulated as compared to the other three groups.  
3.3.2.2 2D-Chondrogenic Lineage 





Figure 3.5: Alcian blue staining of GAG component in 300,000 BMSC condensed 
chondrogenic pellet induced after 3 weeks in different combinations of culture 
medium and concentration of growth factor: proliferative medium with 10ng/ml TGF-
β3 (A) and 20ng/ml TGF-β3 (D); chondrogenic medium with 10ng/ml TGF-β3 (B) 
and 20ng/ml TGF-β3 (E); mixed medium 10ng/ml TGF-β3 (C) and 20ng/ml TGF-β3 
(F). 
 
The Alcian blue staining of GAG component in Figure 3.5 shows that the cell pellet 
was bigger and the blue staining coverage was higher for both chondrogenic medium 
groups (B&E) than other groups. And the normal proliferative medium groups (A&D) 
showed smallest cell pellet after three weeks culture and inside the cell pellet, GAG 
amount was least. It was also interesting to notice that GAG in the mixed medium 
groups (C&F) occurred in all the inner part of the pellet, but missed the out layer of 
the pellet, since the out layer was only stained by nuclear red dyes. While in 
chondrogenic medium groups, GAG staining appeared not only inside the pellet, but 
also along the out layer of the pellet. 





Figure 3.6 tells that both two of chondrogenic medium groups showed much higher 
gene expression levels of all three chondrogenic gene markers than other groups, 
especially for the chondrogenic proteins’ gene maker, collage II and aggrecan. For the 
transcriptional factor SOX9, the difference was bit smaller, but still with the 
chondrogenic medium group with dominant expression and the chondrogenic medium 
group with 10ng/ml TGF-β3 showed slighter higher expression of all three gene 
marker than chondrogenic medium group with 20ng/ml TGF-β3, which was 
consistent with Alician blue staining. 
 
Figure 3.6: Expression of chondrogenic lineage gene markers: Col II (A), SOX 9(B) 




3.3.2.3 2D-Fibroblastic Lineage 
A. Morphology of Differentiated P3 BMSC in  Fibroblastic Lineage 
 
 Figure3.7: Microscopy images of differentiated P3 BMSC cultured with 25ng/ml 
of bFGF in proliferative medium or fibroblastic medium (A) and mixed medium 
(B) 
 
Figure3.7 show the microscopy images of P3 BMSC cultured in different medium, 
and the morphology of the cells was dramatically different. The BMSC in fibroblastic 
medium with bFGF growth factor was elongated and also aligned in certain angels. 
The BMSC in mixed culture medium was tightly packed and the cell looked smaller 




B. Immuno-Fluorescent Staining of Fibroblastic ECM Proteins  
Figure3.8 is the fluorescent microscopy images showing the collagen I staining 
combined with DAPI staining in the same location. It was obviously that both 
fibroblastic medium groups had more staining area of collagen I than the mixed 
medium group at 25ng/ml of bFGF. Due to hyper-confluence of BMSC in mixed 
medium group at 50ng/ml of bFGF, the cells detached from the well plate surface and 








Figure3.8: Fluorescent microcopy images of fibroblastic ECM protein Col I in cell 
groups under different combination of culture medium and concentration of bFGF: 
proliferative or fibroblastic medium with 25ng/ml bFGF (A,D,G) ; mixed medium 








Figure3.9 is the fluorescent microscopy images showing the Col III staining combined 
with DAPI staining in the same location. Overall, the staining of was much less in all 
the groups as compared to Col I. But still it was obviously that fibroblastic medium 
group with 50ng/ml bFGF has most staining area of Col III than the other two groups.  
Again the mixed medium group with 50ng/ml bFGF didn’t have the staining result 
due to hyper confluence of cells and detaching of cells from the culture well plate 
surface. 
Figure3.9: Fluorescent microcopy images of fibroblastic ECM protein Col III in cell 
groups under different combination of culture medium and concentration of bFGF: 
proliferative or fibroblastic medium with 25ng/ml bFGF (A,D,G) ; mixed medium 




C B A F D E I G
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Figure 3.10 is the fluorescent microscopy images showing Tenascin C staining under 
detection of the nuclea stained by DAPI in the same position. It was obviously that 
both fibroblastic medium groups have higher staining area of Tenascin C than the 
mixed medium group at 25ng/ml of bFGF. Again 50ng/ml bFGF mixed medium 
group doesn’t have the staining result due to over confluence of cell and therefore 
detaching of cell from the culture well surface.  
 
Figure 3.10: Fluorescent microcopy images of fibroblastic ECM protein Ten C in cell 
groups under different combination of culture medium and concentration of bFGF: 
proliferative/fibroblastic medium with 25ng/ml bFGF (A,D,G) ; mixed medium with 
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C. Expression of Fibroblastic Lineage Gene Markers  
Figure3.11 shows the expression results of three fibroblastic gene markers (Col I, Col 
III & Ten C). Basically, the gene expression results were consistent with immune-
fluorescent staining results. The two proliferative (or fibroblastic) medium groups 
demonstrated much higher gene expression than two mixed medium groups. 
Furthermore, the fibroblastic group with 25ng/ml bFGF had a bit higher expression 
than fibroblastic group with 50ng/ml bFGF, which was different from staining results.   
 
Figure3.9: Expression of fibroblastic lineage gene markers: Col I (A), Col III (B) and 




3.4.1 Potential of Porcine BMSC as Single Cell Source for in-vitro Bone-
Ligament Interface Regeneration 
Although in previous substantial study, BMSC was proven to have multi-potency by 
two dimensional in vitro tri-lineage differentiation towards osteogenesis, 
chondrogenesis, and adipogenesis, but it was seldom to show that this multi-potency 
can be made use of to build a multi-tissue interface graft regeneration but rather than 
study single tissue regeneration under different stimulus. Ma et al[73] built the bone-
ligament interface by using the BMSC as only cell source and pre-differentiating the 
BMSC into both bone tissue complex and ligament tissue complex in vitro first and 
then transplanting the two tissue complex combined graft into in vivo sheep model for 
bone-ligament interface regeneration. However, it is more challenging to have the 
BMSC as single cell source to study three tissues composing bone ligament interface 
in vitro since the MSC ability and phenotype in vitro culture is different from that 
staying in vivo native microenvironment[99] or called stem cell niche, which is 
considered to be made of native ECM, paracrine signals and accessory cells 
types[100]. And also it is believed that it was very hard to totally mimic the native 
stem cell niche through in vitro 3D scaffold[101].  
From both gene expression results and histology or immune-histology staining results, 
it can be concluded that BMSC have the multi-potency potential as single cell source 
for in vitro bone-ligament interface regeneration. Firstly, the microscopy images 
showed quite different cell morphology of differentiated BMSC, which indicates that 
BMSC was able to differentiate into multi-lineage. Then for each specific lineage, the 
corresponding gene markers were expressed and particular obviously up-regulated in 
induced medium group. Furthermore, the specific ion or protein component was 
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stained out in secreted ECM by differentiated BMSC to show the phenotype 
expression of each specific lineage differentiation. And the highest staining level 
group also occurred in highest gene expression level, which shows consistency in 
both genotype and phenotype.  
3.4.2 Appropriate Culture Medium to Support BMSC Multi-Lineage 
Differentiation for in-vitro Bone-Ligament Interface Regeneration 
By comparing either gene expression level or histology (immune-histology) staining 
level in different experiment groups, it can conclude that BMSC has to be induced 
under different traditional medium, no matter the existence of specific growth factor. 
In other way, it indicates that there is no common single medium to support the three-
lineage differentiation simultaneously, different from what has been done for 
osteochondral graft regeneration with BMSC as single cell source using defined 
osteochondral medium[96, 97].  This might be explained by the total different 
evolution process for osteogenesis and ligamenesis, while the osteogenesis evolutes 
from chondrogensis by further endochondroal ossification of chondrocytes in the 
hyaline cartilage, as what has been discussed in chapter 2 for development of 
fibrocartilaginous enthesis[41].  
The final design of the in-vitro B-L graft is greatly dependent on in vitro stimulus. 
From the hint that particular culture medium is needed for specific differentiation, the 
graft has to be designed with different zones to allow the exposure into different 
medium, while at the same time, isolated from stimulus for each other to avoid the 
interference and in the end still able to form an interface by interaction with each 
lineage. This made the in vitro development of B-L graft more challenging, but still 
possible by well designing graft and controlling the stimulus.  
68 
 
The growth factor was functioned to enhance the differentiation by stimulating the 
differentiation into higher level with higher dosage. However, it was not absolutely 
that higher dosage will induce higher gene or protein expression, as shown in 
chondrogenesis lineage, 10ng/ml TGF-β3 in chondrogenic group has both higher gene 
and protein expression level than 20 ng/ml TGF-β3 chondrogenic medium group. It 
was reported in Mueller’s study that for the effective insulin concentration for 
expression of cartilage differentiation markers is between 0 and 10 µg/ml and higher 
dosage has no additional effect on chondrogenesis[102]. Furthermore, Ohlsson et al’ s 
study  revealed that there is a link between the overdosage of insulin like growth 
factor 2 gene with Wilm’s tumorigenesis[103]. Recently, there are even increasing 
awareness that the high dosage of BMP2 in clinical surgeries, such as spine fusion 
operation may cause some both intraoperative and perioperative complication in 
patients[104].  
Besides, the 2D dosage of growth factor may give hint for designing the dosage 
amount to load into 3D composite scaffold, as what will be shown in chapter 5 that 
two different dosage of growth factor was also introduced for 3D multi-lineage 
differentiation to compare the effect of growth factor for BMSC induction into 




Chapter 4 Study of the Growth Factor Loaded Silk Fibroin Based 
Composite Scaffold as 3D Scaffold System for In Vitro Bone-
Ligament Interface Regeneration  
 
4.1 Introduction  
 
In order to have a successful regeneration of the bone-ligament interface in vitro, the 
other two elements were still needed beside the appropriate cell source based on the 
“three basic elements” principle of tissue engineering. The other two elements were 
biocompatible scaffolds which could support cell attachment, proliferation or 
differentiation and the biochemical cues (or mechanical cues) which could stimulate 
and guide the cell secret the desired ECM. In this chapter, the silk fibroin based 
composite scaffold was made to support BMSC attachment and proliferation and 
three different kinds of growth factors were loaded into the scaffold to stimulate the 
BMSC tri-lineage pre-differentiation in three dimensions. The biocompatibility of the 
scaffold was characterized and the release kinetics as well as the bioactivity of each 
growth factor was profiled to prove the suitability of the scaffold as the 3D graft for 




4.2 Method & Materials 
4.2.1 Fabrication of Silk Fibroin Based Gelatin Microspheres Embedded 
Composite Scaffold  
4.2.1.1 Preparation of Silk Fibroin Solution and Silk Fiber Mesh 
The domestic bombyx mori silk fiber (from Thailand) was degummed to either make 
silk fibroin solution or to be knitted into silk fiber mesh. 0.25% (w/v) of sodium 
carbonate solution was prepared to degum the silk in 100°C for half an hour in order 
to completely remove the outside sericine layer to avoid the inflammation response to 
the cells. The degummed silk fiber was then rinsed in 1L distilled water for three 
times to remove the remaining sericine, followed by drying in 37°C oven.  
1g of dried silk fiber was then dissolved in the 10ml of solvent, which was mixture of 
CaCl2 /CH3CH2OH/H2O in molar ratio of 1:2:8, in 70 °C water bath under magnetic 
stirring until silk fiber complete dissolving and the solution being transparent. After 
cooling down to room temperature, the solution was dialyzed in distilled water for 
three times  using semi-permeable Pierce snake skin pleated  dialysis tubing with 
threshold molecular weight being 10K Dalton, with the first two times keeping one 
hour each, the last time keeping for overnight and each time the distilled water being 
changed. After dialysis, the solution was collected into 50ml Falcon tube and filtered 
to remove some contaminants in the solution. The concentration of the silk solution 
prepared at one time was measured by weighting the averaged dried silk fibroin in 
three different clean microscopic slides (n=3), which was done by dipping 100ul of 
solution onto three different microscopic slides (n=3), followed by drying the slides in 
the 60°C oven for at least 3 hours, and weighting the slides with dried fibroin again, 
then finally calculating the weight difference of the slides. The concentration was the 
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average value of the calculated slides weight difference, and the solution was diluted 
into final concentration of 2wt% and kept at 4°C fridge for further usage.   
In the meantime, the silk fiber mesh was knitted with 16 needles using the knitting 
machine (Silver-reed SK270, Suzhou, China) and then went for degumming, distilled 
water rinsing and 37°C oven drying. Then it was framed onto the stainless rectangular 
needle with configuration of 4.5 cm wide and 8cm long. When both silk fibroin 
solution and silk fiber mesh were ready, they were going for lyophilizing after mixing 
with gelatin microspheres.  
4.2.1.2 Fabrication of Gelatin Microspheres (GM) 
The gelatin microspheres were fabricated using the water-in-oil emulsion method.  
Firstly 10wt% of acidic gelatin (Type A, porcine derived, Sigma) solution was 
prepared by dissolving 1g of gelatin power in 10ml distilled water and heated in 70°C. 
Then the total dissolved 10ml gelatin solution was added dropwise into 40ml edible 
oil to form the water-in-oil emulsion which was kept stirring at 700rpm and 70 °C for 
10 min. Then the emulsion was cooled down in ice water bath and kept stirring until it 
returned to room temperature to allow solidifying of the gelatin microspheres. Then 
the cooled down emulsion was cross linked by 2.5wt% of 10ml of glutaraldehyde 
solution and the cross linking was kept for 2 hours and the emulsion was kept stirring 
to avoid the aggregation of GMs. After cross linking, the acetone solution was used to 
wash the emulsion by vigorous shaking and then centrifuging to remove the oil 
supernatant. The cycle of washing and centrifuging repeated two times in order to 
completely remove the oil. Then the cross linked GMs were rinsed in the glycine 
solution (1mg/ml) to neutralize the residual glutaraldehyde. Finally, the rinsed GMs 
were transferred to freeze dry machine to be lyophilized.  
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4.2.1.3 Loading Growth Factor into Gelatin Microspheres  
Each 1mg of lyophilized GMs was loaded with the growth factor by dripping the 
corresponding concentration of 4μl of each kind of growth factor solution onto the 
lyophilized GMs’ surface and then incubating the GMs overnight at the 4°C fridge. 
The growth factor solution was assumed to be 100% absorbed by the lyophilized GMs 
through swelling since this volume of growth factor solution per mg of GMs was far 
less than saturation volume which the lyophilized GMs could swell. (The Swellability 
of the GMs will be discussed in Section 4.3.1) 
4.2.1.4 Lyophilize Mixture of Growth Factor Loaded GMs and Silk Fibroin 
Solution on Framed Silk Fiber Mesh 
10ml of 2wt% silk fibroin solution were mixed correspondingly with 36mg GMs 
loaded with the growth factor. In order to examine the effect of different GMs 
embedding densities on the morphology of the scaffold, two separate 18mg and 72mg 
of GMs was mixed with another two aliquots of 10ml of 2 wt% silk fibroin solution. 
The GMs and silk fibroin mixture were pippetted in 15ml Falcon tube several times to 
allow even distribution of GMs in the silk solution and then added onto 36cm
2
 (4.5cm 
X 8cm)framed silk fiber mesh placed in the bottom of the polystyrene mold. In order 
to keep the even distribution of the GMs across the fiber mesh, the mold was put 
inside the ultrasonic washing machine with vibration for 30s and then transferred to 
pre-cooled freeze dry machine (Epsilon, Christ, Germany) shelf with a set-up 
lyophilizing program which required for 22 hours to finish the lyophilizing. The 
lyophilized silk scaffold was then treated with 90% methanol solution and was dried 
again through the freeze dry machine for another 6 hours to allow the formation of β –
sheet semi-crystallization. Finally a piece of 36cm
2 
composite scaffold with thickness 
around 1mm was formed with GMs embedded at density of 1mg/cm
2







were also made to examine the effect of GM density 
on porosity). The scaffold samples studied in this project were all cut into the standard 
dimension of (1cm) X (1cm) X (1mm). Table 4.1 summarized the preparation of the 
three groups of scaffolds with different GMs embedding density. 
Table 4.1: Summary of preparation of the four groups of scaffolds with different GMs 




) 18mg of GM mixed with 10ml of 2wt% silk fibroin solution and 
pipetted on 8cm X 4.5cm silk fiber mesh 
B (1.0 mg/cm
2
) 36mg of GM mixed with 10ml of 2wt% silk fibroin solution and 
pipetted on 8cm X 4.5cm silk fiber mesh 
C (2.0 mg/cm
2
) 72mg of GM mixed with 10ml of 2wt% silk fibroin solution and 
pipetted on 8cm X 4.5cm silk fiber mesh 
 
4.2.2 Characterization of Silk Fibroin Based GMs Embedded Composite 
Scaffold 
4.2.2.1 Characterization of Microspheres & Scaffolds Morphology and Size 
The GMs were dissolved in water and observed by phase contrast light microscope 
(Olympus IX71, Japan) and analyzed using image analysis software 
(MicroImagev4.5.1, Olympus, Japan) to identify the spherical shape and detect the 
rough range of particle size. Then the laser particle analyzer (Lecia, USA) was used to 
characterize the exact size range distribution of the lyophilized GMs.  Furthermore, 
the scanning electrical microscope operated at high voltage of 10KV (SEM, JEOL 
JSM-5600LV, Japan) visualized the surface morphology of the GMs as well as the 
silk fibroin composite scaffold with different GMs embedding density by coating the 
samples with platinum for 90s using a Sputter Coater (BAL-TEC, PA, USA) before 
the scanning. Besides, the mercury porosimeter (Micrometrics, USA) was used to 
measure the average porosity and pore size of the composite scaffolds with different 
GMs embedding density.  
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4.2.2.2 Characterization of Composite Scaffold Biocompatibility  
The biocompatibility of the composite scaffold needed to be characterized before 
being used as the 3D scaffold for in vitro bone-ligament interface regeneration. 
Basically, C2C12 cell line was seeded at the density of 10,000 per scaffold (n=3) and 
cultured in 24 well plate with 1ml of L-G DMEM culture medium (10% FBS, 1% 
P/S). Alamar blue assay kit (BioSource International, CA, USA) was used to 
quantitatively characterize the viability of the seeded cell by adding 100μl blue assay 
solution into 1ml of culture medium in each well and incubating the mixture solution 
at 37°C incubator for 1 hour. The Alamar blue assay was normally reduced to purple 
pink from blue by the metabolic products of the viable cells during the incubation. 
After 1 hour of incubation, 200μl of the mixture was collected and added into 96 well 
plates for absorbance measurement at wavelength of 570mm and 600mm (600mm is 
reference wavelength) in a microplate reader (Sunnyvale, CA, USA). The percentage 
of reduction of Alamar blue assay was calculated based on the equation and 
absorbance value measured (Equations refers to Appendix A). The reduction was 
measured at four different time points which were day 3, day 7, day 14 and day 21. 
The homogenous silk fibroin scaffold without GM embedded was fabricated and 
seeded with the same population of C2C12 cell as the positive control for this cell 
viability study. 
Beside, Fluorescein diacetate (FDA) (Molecular Probes, Invitrogen Corporation, USA) 
was prepared at the concentration of 5 μg/ml by dissolving in sterilized 1XPBS. Then 
10μl of FDA solution was added onto each scaffold and incubated for 30 min at room 
temperature in the darkness to stain the viable cell on the scaffold. After incubation, 
the scaffold was washed with 1XPBStwice before imaging by confocal microscopy. 
FDA staining was taken at three different time points of day 3, day 7 and day 14. 
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Again the homogenous silk fibroin scaffold was seeded with the same population of 
C2C12 cell and stained by FDA dyes also as positive control group for viable cell 
staining characterization. 
In order to characterize the cell attachment and interaction with the scaffold to prove 
the good biocompatibility of the scaffold, SEM was also taken for the C2C12 seeded 
scaffold after culturing for 7 days. But the samples had to be fixed with 10% formalin 
solution first, then washed with distilled water twice and dried in fume hood. The 
coating and visualization of the samples followed the same steps as stated in Section 
4.2.2.1. 
4.2.3 Quantifying the Release Profile of the Growth Factor from the Composite 
Scaffold 
The loading amount of each kind of growth factor in one piece of standard scaffold 
for the release study was 800ng BMP2, 250ng TGF-β3 and 400ng bFGF separately 
and the GM embedding density at the standard scaffold was 1mg/cm
2
. Basically, one 
piece of standard scaffold sample was dissolved in 1ml of 1XPBS buffer solution or 
1ml of 100 μg/ml Collagenase containing 1XPBS buffer solution and incubated at 
4 °C and kept shaking. At each time point, the buffer solution was collected and 
refreshed with the new buffer. Then the collected release buffer sample was stored in 
-20 °C fridge first and waited for all time points’ samples to be measured using the 
corresponding ELISA kit (R&D System, Minneapolis, USA). For different kinds of 
growth factor, the principle and measurement protocols were almost the same except 
the different primary antibody coated plates.  The protocol of ELISA measurement 
was attached in Appendix D.  
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4.2.4 Measure the Bioactivity of the Growth Factor Loaded into the Composite 
Scaffold 
The loading amount of each kind of growth factor as well as GMs embedding density 
of the scaffold used in the bioactivity study was the same as the release study.  
However, all the growth factor loaded scaffolds were sterilized by ETO process first 
before the cell seeding and culturing. 100,000 P3 BMSC (for BMP2 and TGF-β3 
bioactivity) or 100,000 fibroblasts (for bFGF bioactivity) were seeded on each 
sterilized scaffold and cultured in 24 well plate. As the negative control, the 1mg/cm
2
 
GMs embedded composite scaffold without any growth factor were also sterilized and 
seeded with the same population of cells for this bioactivity study. In order to allow 
the complete attachment as well as stabilization of seeding cells onto the scaffold, 1ml 
of culture medium was pipetted into each well plate only after incubation the cells 
suspension seeded scaffold for 3 hours in 37 °C incubator without any medium.    
4.2.4.1 Study of Loaded BMP2 Bioactivity as Osteogenesis Stimulator  
It was proved that the active BMP2 could stimulate the cellular alkaline phosphatase 
(ALP) activity. Therefore, the loaded BMP2 bioactivity was measured by quantifying 
the ALP expression level per cell, which was calculated by normalizing total ALP 
activity by total DNA amount in one scaffold. The total ALP activity was measured 
by p-Nitrophenyl Phosphate(PNPP) kit (Thermo, IL, USA), while the total DNA was 
quantified by Pico-Green assay (Molecular Probes, Invitrogen, USA). For each assay, 
triplicate of samples (n=3) was collected and measured at two different time points, 
which were day 3 and day 7 post cells seeding. The protocol of ALP assay and Pico-
Green assay were attached in Appendix B & C separatively.  
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4.2.4.2 Study of Loaded TGF-Β3 Bioactivity as Osteogenesis Inhibitor 
It was proved that active TGF-β3 could enhance the chondrogenesis of BMSC and 
inhibit the osteogenesis, therefore decreasing cellular ALP activity. Based on this, the 
TGF-β3 bioactivity loaded into the scaffold was also quantified by measuring the 
ALP expression level per cell, but they were correlated in an inverse way. The seeded 
cell type, population, culturing period and assay time points were the same as those in 
measuring BMP2 bioactivity. 
4.2.4.3 Study of Loaded bFGF Bioactivity as Proliferation Stimulator 
It was proved that active bFGF could stimulate the fibroblastic differentiation of 
BMSC or fibroblasts proliferation. Therefore, the bioactivity of bFGF was measured 
by quantifying the population of proliferated fibroblasts in the scaffold, which could 
be directly quantified using Pico-Green assay. The culturing period and assay time 
points were the same as measuring BMP2 and TGF-β3 bioactivity.  
4.2.5 Statistical analysis 
All data were expressed as mean ±standard derivation (SD). Significance analysis was 
performed by pairwise comparison of experimental groups (n=3) using two-tailed, 
unpaired student T-test, using the excel software. A p value <0.05 was considered as 




4.3.1 Morphology of GMs and Composite Scaffolds 
As shown in Figure4.1, the morphology of the GMs was spherical while the size was 
varied.  Figure4.2 further shows the GMs size distribution and there were two main 
ranges detected which were 100µm-200µm and 400µm-700µm, and two minor size 
ranges which were 0μm-50μm, and 50μm-100μm. The size of the GM shown in 
Figure4.1 was mainly between 100µm-200 µm which was selected by filtering with 
the set of stainless sieves (Relstch, German) with 200μm pore size and 100μm pore 
size sequentially. Furthermore, Figure 4.3 shows SEM images of the lyophilized GMs, 
of which the surface looked smooth and didn’t have any big crack or wrinkles on the 
surface 
 
Figure4.1: Light microscopy images of GMs dissolved in distilled water at 
magnification of 40 (A) and 100 (B) 
 




















Figure 4.3: SEM images of lyophilized GMs at different magnification: 100 (A); 300 
(B); 1500(C); 3000(D) 
 
Besides, the Swellability of the lyophilized GM was calculated based on the 
percentage of weight change after swelling at different time points. The Swellability 
was quantified to guide the loading volume of the growth factor and make sure the 
volume swelling into the microspheres was unsaturated. Figure4.4 shows that there 
was significant weight percentage change between 12 hours and 3.5 hours, but no 
more significant weight percentage change between 12 hours and 7 hours, which 












Figure 4.4: Swellability of lyophilized GM (*p<0.05 for T-test) 
Table4.2 summarise the average porosity and pore size of the scaffolds with different 
GMs embedding density. Overall, with the GM embedding density increasing, the 
value of the average porosity and pore size became lower. The scaffold with GMs 
embedding density of 0.5mg/cm
2
 had average porosity value around 90% and average 
pore diameter around 51 µm.  At density of 1mg/cm
2
, the scaffold could still keep the 
average pore diameter around 50 µm and porosity around 86%. However, the average 
pore diameter significantly reduced to around 40μm at density of 2mg/cm2 and the 
average porosity further reduced to around 84%, which was also considered 
significantly lowered than porosity value at density of 0.5mg/cm
2
. 
Table 4.1: Average Porosity and pore diameter among scaffolds with different GMs 





Average Porosity (%) Average Pore Diameter 
(µm) 
0.5 90.1 51.2 
1 86.1 50.6 
2 83.9* 40.2* 
































Meanwhile, the SEM images in Figure4.5 also characterize the difference of pore size 
as well as GMs distribution in the scaffolds with different GMs embedding density. 
The three different columns of images corresponded to the surface images of 
composite scaffolds at GM embedded density of 0.5mg/cm
2 
(A, D, H), 1.0mg/cm
2
(B, 
E, I) and 2.0mg/cm
2
 (C, F, G)
 
respectively.  And the three different rows of images 
corresponded to the SEM pictures visualized at different magnifications of 50(A, B, 
C), 100(D, E, F) and 200 (H, I, G).  The rectangular white box indicated the area to be 





Figure4.5: SEM images of composite silk fibroin scaffolds with different GM 
embedding density of 0.5 mg/cm
2 
(A, D, H); 1mg/cm
2 
(B, E, I); 2mg/cm
2 
(C,F,G); at 
different magnification of 50 (A, B, C), 100 (D, E, F) and 200 (H, I , G) (White 
rectangular box indicating the area to be further magnified and white arrows 




Overall, it was seen that the pores within the scaffolds kept interconnected even with 
GMs embedded from the first rows of images (A, B, C).  From the further magnified 
images at 100 times (D, E, F), it was seen that pore sizes of the scaffold at density of 
2mg/cm
2
 were obviously smaller than the other two groups due to embedding of 
much more GMs, which was consistent with the measured average pore diameter 
value comparison. The porosity in this group of 2mg/cm
2 
also looked significantly 
reduced by too many GMs blocking the openings within the scaffolds. While the pore 
size and porosity of the scaffold at density of 1mg/cm
2 didn’t see obvious difference 
with the group of density of 0.5mg/cm
2
. Looking at the GMs distributions images (H, 
I, E), GMs stayed aggregate at density of 2mg/cm
2
 while GMs was  evenly distributed 
at density of  1.0mg/cm
2
. However, there were too less GMs detected in the group 
with density of 0.5mg/cm
2
 as compared to the other groups although the pore size and 
porosity was well maintained in this group.  
From both porosity and pore size measurement and SEM characterization, it was 
concluded that the density group with 1.0mg/cm
2
 should be optimal for GM 




4.3.2 Biocompatibility of Composite Scaffolds with C2C12 Cell Lines 
Figure 4.6 shows reduction profile of Alamar blue assay in the culture medium of 
C2C12 seeded homogenous silk scaffolds and composite silk scaffolds at four 
different time points, which were day 3, day 7, day 14 and day 21. The reduction of 
Alamar blue assay was positively correlated to the viability of the cell, which meant 
that the cells on the scaffolds were more viable, the reduction value of assay was 
higher. The viability of the cells on the scaffolds could further tell the cytotoxicity or 
the biocompatibility of the scaffolds.  
It was seen from both curves that there was increase in reduction value for both 
composite and homogenous silk scaffolds from day 3 to day 7, followed by the 
decrease from day 7 to day 21.  Therefore the two curves had similar metabolic trends 
of the viable cells on the two kinds of scaffolds. Furthermore, there was no significant 
difference between reduction values of two kinds of scaffold at each time point, which 
implied the cell viability in these two groups was comparable and further confirmed 
that there was little cytotoxicity of the composite silk scaffold with the glutaraldehyde 
cross linked GMs 
.  
Figure 4.6: Reduction of Alamar blue assay in culture medium for both homogenous 































The confocal imaging of the viable cell stained by FDA was shown in Figure 4.7. The 
images were compared again between the homogenous scaffolds (A, B, C) and 
composite scaffolds (D, E, F). The staining results were consistent with Alamar blue 
assay reduction, which showed most viable cells at day 7 in both two groups, then 
decreased after that. Furthermore, the stained viable cells looked comparable in two 
groups, similar to the comparison of Alamar blue assay reduction values between 
these two groups.   
 
Figure4.7: Confocal images showing the FDA stained viable cells across the thickness 
of both homogenous(A, B, C) and composite scaffolds (D, E, F) at times points of day 





Moreover, SEM images in Figure4.8 further characterize the cell attachment on and 
interaction with the composite scaffolds. The red arrows in images A&B indicated the 
position of the cells attached on the scaffold. It was seen that the cell were well spread 
out on the surface of the scaffold. The images C&D showed the partial degradation of 
the GMs as well as encapsulation of the GMs by the cell, implying that the GMs were 
not toxic and attracted the cells migration.   
  
Figure4.8: SEM images showing cell attachment and interaction with the composite 
scaffolds at different magnification: 50(A); 100 (B); 200(C); 300(D) (Red arrows 






4.3.3 Release Profile of the Growth Factor from the Composite Scaffold 
The release profile of each kind of growth factor from the composite scaffold was 
plotted against the time points. The BMP2 release profile from the composite scaffold 
is shown in Figure4.9. The concentrations of two different BMP2 release buffer 
solutions were measured at time points of day 1, day 4, day 10, day 16 and day 22 and 
day 27 from 800ng BMP2 loaded composite scaffolds. From the release profile, it was 
seen that around 61% of total BMP2 was released out within 27 days in collagenase 
PBS buffer, almost double of 33% total release in normal PBS buffer solution. At day 
1, the burst release of BMP2 was as small as around 6% in PBS buffer, while it was 
around 10% in collagenase PBS buffer, again almost double the value in PBS buffer 
at the same time point, implying the linear trends of both release curves. The 
regression curve in both release profiles showed the R
2
 value almost equal to 1, 
confirming the linear release profile of BMP2.  
 






R² = 0.9937 





















TGF-β3 release profile was measured within 14 days only from 250ng TGF-β3 
composite scaffolds in both release buffer solutions, at time points of every day.  
From Figure4.10, it was seen that the total release at day 14 was around 46% and 26% 
in collagenase PBS buffer and PBS buffer repetitively. The burst release at day 1 still 
kept low and even lower than that in BMP2 release profile. The regression curve had 
a bigger deviation of R
2
 value from 1 as compared to the R
2
 value of regression curve 
for BMP2 release profile. However, it still looked like linear curve.  
 






R² = 0.9642 























Last but not least, bFGF release profile was measured from 400ng bFGF loaded 
composite scaffold in same time interval and time points as TGF-β3 and shown in 
Figure4.11. However, the total release for bFGF in collagenase PBS buffer at day 14 
was only 29%, much less than that in TGF-β3 release profile, but more than twice of 
13% bFGF total release in PBS buffer at the same time point. Again, the bFGF burst 
release at day 1 was around 6% and 5% in collagenase PBS buffer and normal PBS 
buffer respectively, both higher than those of TGF-β3 burst release at the same time 
point.  The small difference of two bFGF burst release value at day 1 and increased 
difference of two bFGF total release values at day 14 indicated that bFGF release was 
more affected by the difference of the buffer solution than the other two growth 
factors. The regression curve saw bigger deviation of R
2 
value from 1 in PBS buffer 
group than collagenase PBS buffer, indicating the bFGF release curve in PBS buffer 
was less linear that that in collagenase PBS buffer. But overall two curves looked 
linear.
 





R² = 0.9345 























4.3.4 Bioactivity of the Growth Factor Loaded in Composite Scaffolds 
Besides of the release profile, the bioactivity of each kind of growth factor was also 
quantified. The bioactivity of BMP2 loaded in composite scaffolds was positive 
correlated with normalized cellular ALP activity level. Figure4.12 showed normalized 
ALP levels in both 800ng BMP2 loaded composite scaffolds (labelled as BMP2 (+)) 
and no BMP2 loaded composite scaffolds (labelled as BMP2 (-)) at two time points, 
which were day 3 and day 7. It was seen that there were significant higher ALP 
activity in BMP2(+) group than BMP2(-) group at both time points. And there was 
also significant increase of ALP level from day 3 to day7 in BMP2(+) group, however 
there was no significant increase from day 3 to day 7 at BMP2(-) group, indicating it 
that the 800ng BMP2 loaded in the composite scaffold maintained bioactive at least 
up to day 7.  
 
































The TGF-β3 bioactivity was also quantified by normalized cellular ALP activity, but 
negative correlated with the ALP level. Figure 4.12 shows the normalized ALP level 
in both no TGF-β3 loaded scaffold group (labelled as TGF-β3(-)) and 250ng TGF-β3 
loaded scaffold group(labelled as TGF-β3(+)) at day 3 and day7. It was seen that the 
normalized ALP level in TGF-β3(-) group was significant higher than that in TGF-
β3(+) group at day 3, and also there was a significant increase of normalized ALP 
level from day 3 to day 7 in TGF-β3(-) group, while there was no significant increase 
in TGF-β3(+) group, implying that the 250ng TGF-β3 loaded in the scaffold 
maintained bioactive up to day 7 and  inhibited cellular ALP activity increase with the 
time.   
 
































The bioactivity of bFGF loaded in composite scaffolds was measured by the DNA 
concentration only since active bFGF was proven to induce fibroblast proliferation.  
Figure 4.13 told there was no significant difference of DNA concentration at day 3 
between no bFGF loaded group (labelled as bFGF(-)) and 400ng bFGF loaded 
composite scaffold(labelled as bFGF(+)).  However, the DNA concentration at day 7 
was significant different between these two groups, with significant higher DNA 
concentration in bFGF(+) group. Besides, there was no significant increase of DNA 
concentration in bFGF(-), but significant increase in bFGF(+) group from day 3 to 
day 7, indicating the bFGF bioactivity was well maintained at least up to day 7.    
 




































4.4.1 GMs Embedded Silk Fibroin Composite Scaffolds as Biological Stimulus 
Reservoir for BMSC Tri-Lineage 3D Differentiation 
In Chapter 3, it was already shown that BMSC had the potential to be the single cell 
source for in vitro bone ligament interface regeneration. Moreover, it was shown that 
the growth factor had the enhancing effect on BMSC 2D tri-lineage differentiation 
besides of the conventionally induced culture medium. In order to incorporate the 
biological stimulus for BMSC 3D tri-lineage differentiation in a sustainable way, the 
silk fibroin based composite scaffold was therefore fabricated by loading each 
specific growth factor into cross-linked GMs. Our group has already studied the 
combined silk scaffolds with web like micro-porous silk fibroin sponge in the 
openings of knitted silk mesh for ligament tissue engineering [27].  But this scaffold 
prototype had to be modified in order to be more suitable for in vitro bone-ligament 
interface regeneration.  
 
Direct loading of growth factor into silk fibroin sponges only retained 25% of BMP2 
within one week in David Kaplan’s study [90]. However, Mikos group[84] showed 
sustainable release of 60% BMP2 within one month from glutaraldehyde cross-linked 
GMs and 70% cumulative release of BMP2 within one month from GMs embedded 
composite scaffolds. Since the growth factor had to stimulate the BMSC pre-
differentiation at least up to 3 weeks, it was preferable that the release profile could be 
more sustainable by incorporating the growth factor into the GMs, which was further 
embedded into the silk fibroin scaffold. From the release profile of three growth 
factors from the composite scaffold, it was concluded that the GMs embedded silk 
fibroin scaffold could release the growth factor continuously and stimulate the BMSC 
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3D differentiation sustainably. The release profile also tended to be linearly within the 
time interval and had small burst release in the beginning.  
 
In this study, the growth factor was loaded into the lyophilized GMs through swelling 
and then formed physical ionic complexation with acidic GMs[105]. The release 
mechanism was hypothesized in a manner that the balance of ionic bonding was 
broken down by hydrogen bonding in the water molecules in neutral (pH=7) PBS 
buffer under mechanical agitation. The collagenase containing PBS buffer enhanced 
the release by further breaking down the covalent bonding between the gelatine 
molecules from glutaraldehyde cross linking and leading to the degradation of the 
GMs. During the degradation of the GMs, the growth factor molecules were detached 
from the GMs and then diffusing out from the silk fibroin sponge into the release 
buffer. There was no obvious burst release in the beginning while kept the continuous 
release probably due to this hypothesized release mechanism.  
 
Besides, the bioactivity of each kind of growth factor loaded in the scaffold was well 
maintained up to seven days by referring to the growth factor stimulating or inhibiting 
cellular activity. Usually the free form of growth factor solution was unstable due to 
proteolysis[105]. Due to the ionic bonding between the negative charged growth 
factor and positive charge GMs, the growth factor remained its bioactivity after 
loading. Furthermore, the localized and direct delivery of the growth factor to the 
cells attached on the GMs embedded composite scaffold further kept the bioactivity of 
the growth factor by preventing the dilution effect in solution[105] 
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4.4.2 GMs Embedded Silk Fibroin Composite Scaffolds as 3D Support for 
BMSC Proliferation & Differentiation 
In order to mimics the native microenvironment for better proliferation and 
differentiation of stem cell, three dimensional scaffold was a necessity by providing 
large surface area of anchorage for stem cell attachment and then stimulating the 
cellular signal pathways which directed the stem cell proliferation and further 
differentiation[101], which was the way that the native ECM interact with stem 
cell[106]. 
 
Among all the 3D scaffolds, the sponges based composite scaffold with microspheres 
embedded became competitive by combining both advantages of good porosity from 
sponges and good biological stimulus delivery vehicles as microspheres. Many 
studies had shown that the various composite scaffolds with microspheres embedded 
in porous polymer scaffolds maintained the porosity and reduced the burst release of 
growth factor [92, 94, 107]. Besides, the mechanical properties was proven to 
improve due to slight increase in compressive modulus and made it more suitable for 
both cartilage[107] and bone tissue engineering[108]. 
 
In this thesis, the silk fibroin based composite scaffolds with GMs embedded at 
different density were fabricated and it was found that 1mg/cm
2
 was the optimal GMs 
embedding density based on both porosity measurement and SEM morphology 
characterization. From the SEM images, it was seen that the pores within the scaffold 
kept well interconnected and the GMs were also well distributed throughout the 
scaffold, embedding either on the walls or intersections of the scaffold.  Overall, the 
porosity at this density were not affected too much since the porosity was still high 





The average pore size of this composite scaffold was around 50μm, still in the range 
of 20 μm-100 μm as reported in our previous work for ligament regeneration[27]. 
From the SEM images showing the attachment of C2C12 cell on the scaffold, it was 
concluded that this composite scaffold well supported cell spreading and attachment 
since the cells kept connected instead of isolating from each other. Besides, the cells 
not only attached on the silk fibroin sponge wall but also wrapped on the GMs’ 
surface. There was aslo some partial degradation of the GMs, implying the good 
interaction of the cell with the overall structure of the composite scaffold.    
 
Besides, based on both quantitative Alamar blue assay reduction profile and 
qualitative confocal microscopy imaging of the viable cells on the scaffold, it showed 
the composite scaffold had comparable biocompatibility with the homogenous silk 
fibroin scaffold, which was already reported in previous studies that they were good 
biomaterial based scaffolds for ligament tissue engineering[18, 27, 28, 78]. There the 
glutaraldehyde cross linked GMs had little cytotoxicity and showed the good 




Chapter 5 3D BMSC Differentiation on Individual Composite 
Scaffold with Specific Growth Factor Loading as Pre-Differentiation 




In Chapter 3, it was already shown that there was no common medium for 
simultaneous induction of BMSC tri-lineage differentiation for bone-ligament 
interface regeneration in vitro. The BMSC had to be induced under each specific 
medium even with the presence of the growth factor. In Chapter 4, it was shown that 
the growth factor loaded composite scaffold was biocompatible for cell proliferation 
and attachment, and also provided the growth factor cues in a sustainable way. 
Therefore, in this chapter BMSC tri-lineage 3D differentiation was going to take 
under each specific induced medium and also on each specific growth factor loaded 
composite scaffold individually yet still side by side. Moreover, this chapter was 
considered as BMSC tri-lineage 3D pre-differentiation before integration and co-
culture to allow further differentiation as well as forming the bone-ligament interface.   
 
Similarly to BMSC tri-lineage 2D differentiation, two different amounts of growth 
factor loading were introduced for each lineage. Besides, the composite scaffold 
group without any growth factor was added as negative control. The gene expression 
and histology staining results were measured to characterize the success of the pre-
differentiation after three weeks induction culture.  
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5.2 Materials and Methods 
5.2.1 Building Different Growth Factor Loaded Composite Scaffolds with 
Different Loading Amounts  
The growth factor loading for each lineage 3D pre-differentiation was summarized in 
Table 5.1. Basically, as stated in Section 4.2.1.3, 4μl of growth factor solution at 
specific concentration was loaded into 1mg of lyophilized GMs, which was finally 
embedded into one piece of standard scaffold (1cm
2
). Therefore, the final loading 
amount of growth factor into one piece of standard scaffold was equal to the multiple 
of volume 4μl with the concentration, as listed in the Table5.1. The three different 
growth factor loading concentration and amount groups in one lineage were also listed 
in this table. The negative control group had no growth factor loading. Besides, all the 
scaffolds were sterilized by ETO process before seeding with BMSC.  
Table5.1: Summary of the growth factor loading concentration and amount for each 
lineage (n=3 as number of different loading groups per one lineage, n=9 as number of 
the samples per each loading group) 









Negative 0 0 0 
Sample 1 100 31.25 50 
Sample 2 200 62.5 100 
Loading amount 
(ng) 
Negative 0 0 0 
Sample 1 400 125 200 
Sample 2 800 250 400 
 
5.2.2 Seeding and Culturing BMSC for 3 Weeks Pre-differentiation  
100,000 P3 BMSC was harvested from confluent P2 BMSC and seeded onto one 
piece of standard scaffold at GMs embedding density of 1mg/cm
2
. The BMSC seeded 
scaffolds were all cultured in 24 well plates with 1ml of specific induced medium, 
which was changed every three days until 3 weeks long. Then the scaffolds were 
harvested for different assay following the specific protocols. Total nine scaffolds 
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(n=9) were studied for one growth factor loading group(in terms of one concentration 
or amount) in one lineage. Duplicate of them were collected for SEM, confocal 
microscopy imaging and histology (or immunohistochemistry) staining separately. 
Triplicate of them were collected for RNA quantification.  
5.2.3 Microscopy Characterization of BMSC Tri-lineage 3D Pre-Differentiation 
5.2.3.1 SEM Characterization of 3 Weeks Pre-Differentiated BMSC on 
Composite Scaffolds  
After three weeks of BMSC culturing in induced medium, duplicate of scaffolds(n=2) 
in one growth factor loading group in one lineage were collected from the well plates , 
therefore totally 6 pieces of scaffolds were collected for one lineage(No. of Groups=3)  
In order to see how BMSC interacted with scaffold as well as the pre-differentiated 
BMSC morphology in each lineage, SEM imaging was taken and the samples were 
first treated with 10% formalin solution for 24 hours and then washed by distilled 
water twice and dried in fume hood for 6 hours before coating with platinum and 
scanned under SEM.  
5.2.3.2 Confocal Microscopy Imaging of Live/Dead 3 Weeks Pre-Differentiated 
BMSC on Composite Scaffolds 
Another duplicate of samples in one growth factor loading group in one lineage were 
collected and stained by live/dead viability/cytotoxicity assay kit (Invitrogen, USA). 
This assay kit contained two fluorescent dyes, which not only stained the viable cell 
to green color by calcein, but also stained the dead cell to red by ethidium 
homodimer-1(EthD-1). Before staining the scaffold, the kit was thawed from -20°C 
freeze and warmed to room temperature. Then 2mM EthD-1 solution was diluted into 
4μM by adding 2μl of red EthD-1 solution into 1ml of sterilized 1XPBS solution and 
vortexing. Another 0.5 μl of 4mM calcein solution was added into 1ml of diluted 
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EthD-1 to form the diluted 2 μM calcein solution. Then 100 μl-200μl of diluted dye 
solution was added onto the scaffold, which was incubated in room temperature for 30 
min in the darkness and then washed by 1XPBS solution before scanning under 
confocal microscope.  
5.2.4 Quantitative RT-PCR Analysis of Gene Expression of 3 Weeks Tri-
Lineage Pre-Differentiated BMSC  
Triplicate of scaffolds for one growth factor loading group in one lineage (n=3) were 
collected for gene quantification. Therefore, total 9 pieces of scaffolds in one lineage 
were collected and digested by adding 1m of Trizol solution into each sample to 
extract the total RNA. The volume of extracted RNA solution for reverse transcription 
into cDNA was calculated by dividing total 200ng RNA by the measured RNA 
concentration. RNA extraction, cDNA synthesis, real time PCR, and calculation of 
normalized gene expression all followed the same protocol as stated in Section 3.2.2.   
The gene markers primer sequences were also the same as listed in Table3.3.   
5.2.5 Histological & Immunohistochemistry Staining of Tri-Lineage 3D Pre-
Differentiated BMSC 
5.2.5.1 Hematoxylin and Eosin (H&E) Staining 
Besides quantifying the gene expression, the differentiated ECM as well as the 
specific component of differentiated ECM was characterized by different staining 
methods.  
 
The pre-differentiated BMSC as well as secreted ECM was stained by Hematoxyline 
and Eosin staining. This staining was done for all tri-lineage. Before staining, the 
samples were fixed by 10% formalin solution for 24 hours and then washed by 
1XPBS solution twice. Then the scaffold was embedded into tissue freezing 
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medium(Cryomatrix, Thermo Scientific), which was liquid solution  at room 
temperature but solidified at -20°C, and then cut into slice of 10µm thickness using 
Cryostat machine (Leica, USA) and mounted onto the positive charged silicon slides. 
The mounted slice of the scaffold was washed by distilled water first to remove the 
freezing medium and then stained by the Hematoxyline solution for 5 min, followed 
by rinsing with tap water, dipping into Scotts water for 10s, and into differentiation 
solution for another 5s, rinsing with tap water again, then stained by Eosin solution 
for 5s. After this, the slide was dehydrated in series of ethanol solution with gradient 
concentration of 50%, 70%, 90% and 100% sequentially, with soaking in each 
concentration of ethanol solution for 2 min before transferring into next concentration. 
Then the slide was cleaned in fresh 100% xylene and air dried in the fume hood. 
Finally the slide was covered using the Depax mounting medium Glurr (VWR) and 
cover slip.  
5.2.5.2 Alizarin Red and Alician Blue Staining 
In order to indentify the specific lineage of differentiation, extra staining was done to 
characterize the ECM proteins or ions. Similarly to BMSC tri-lineage 2D 
differentiation study, Alizarin Red staining was done to characterize the calcium ions 
deposition in osteogenic differentiated ECM, while Alician blue staining was done to 
characterize the GAG component in chondrogenic differentiated ECM. The staining 
protocols were the same as stated in Section 3.2.2 except these two staining was done 
on mounted scaffold slice instead of on the culture well plate. Therefore, it had to 
follow the same procedures of washing, dehydrating and mounting the slides as stated 
in Section 5.2.5.1 for H&E staining.  
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5.2.5.3 Immunohistochemistry Staining 
Similar as the principles of immunofluorescent staining for 2D fibroblastic 
differentiated ECM proteins as stated in Section 3.2.2, the immunohistochemistry 
staining of Col I, Col III & Ten C in 3D fibroblastic differentiated ECM was done by 
allowing the ECM protein to chemically react with two different antibodies first 
before being stained by the dyes. But the reagents and the procedures of 
immunohistochemistry staining were different from those in immunofluorescent 
staining. The UltraVision Detection System Anti- Mouse, HRP/DAB kit (Fisher 
Scientific, USA) was used for immunohistochemistry staining. 
 
Briefly, hydrogen peroxide was dripped onto the slice to block endogenous 
peroxidase by incubation with the scaffold slice for 15 min at room temperature. Then 
the slice was washed twice by PBS and pepsin solution was added further and 
incubated for another 20 min to allow the antigen epitope recovery and presentation. 
Before adding the primary antibody, Ultra V block solution were added first and 
incubated for 5 min to block the unspecific binding of the primary antibody with other 
antigens. Then the three primary antibodies Col I (Sigma, USA), Col III and Ten C 
(Millipores, USA)  were diluted in 1:1000, 1:200, 1:200 respectively,  and incubated 
with individual scaffold slice for 2 hours at room temperature to allow enough 
reactions with the specific protein antigen. After primary antibody incubation and 
washing by PBS buffer twice again, biotin-conjugated secondary antibody was 
dripped onto the slice and incubated for another 30 min to allow further binding with 
primary antibody. After that, streptavidin peroxidase in the kit was added and 
incubated for 45 min to allow the conjugating with biotin in the secondary antibody 
and then washed by PBS twice. Finally, 1 drop of DAB chromogen was mixed with 
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1ml of DAB substrate and the DAB chromogen/substrate mix was added onto the 
slice. The brown color came out after incubation for about 1-3 min when the detected 
protein existed in the ECM.  The counter staining of the cells by hematoxylin solution 
was further done after the immunohistochemistry staining. 
5.2.6 Statistical analysis 
Statistical analysis was taken for gene expression results. All data were expressed as 
mean ±standard derivation (SD). Significance analysis was performed by pairwise 
comparison of experimental groups (n=3) using two-tailed, unpaired student T-test, 





5.3.1 BMSC Pre-Differentiated into Osteogenenic Lineage 
 
Figure5.1: Confocal Microscopy Imaging of Osteogenic Pre-Differentiated BMSC on 
different amounts of BMP2 loaded composite scaffolds at Week 3: No BMP2 loaded 
(A); 400ng BMP2 loaded (B); 800ng BMP2 loaded (C) 
 
Figure5.1 showed confocal microscopy images of the live and dead BMSC on 
different amounts of BMP2 loaded composite scaffolds after culturing for 3 weeks for 
osteogenic pre-differentiation. These images of the live/dead BMSC were Z-stacked 
throughout the whole thickness. It was clearly seen that abundant live BMSC stained 
in green in the scaffold, while the dead BMSC was not obvious detected although 
there were some staining in red, which was probably the auto-fluorescence of the silk 
fibroin scaffold since the red staining looked quite like the outline of the scaffold. 
Besides, it was noticed that the GMs were in bright green color in the images. This 
was probably also due to its strong auto-fluorescence of GMs after cross-linking, as 
reported somewhere else[109]. But it might also be due to the abundant live BMSC 
attached on the GM surface, as it was shown in SEM images in Figure 5.2. Besides, it 
seemed that the number of viable BMSC occurred in the confocal images was 
somehow positive related to the amount of BMP2 loading since the group  with 800ng 
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BMP2 loaded had most green stained BMSC than the other two groups, which had 
less loading amount of BMP2. It might indicate that BMP2 loading enhanced the 
BMSC osteogenic differentiation or at least increased the cell proliferation. It might  
 
Figure5.2: SEM characterization of osteogenic pre-differentiated BMSC on different 
amounts of BMP2 loaded composite scaffolds at week 1 (A, B, C) and week 3(D, E, F) 
 
SEM images in Figur5.2 demonstrated the morphology of osteogenic pre-
differentiated BMSC and ECM on composite scaffolds with different BMP2 loading. 
The cell attachment and ECM deposition onto the scaffold surface increased with time. 
At week1, there were still gaps existing between cells and scaffold surfaces since the 
pores within the scaffold were still present in all the three groups. At week3, the 
scaffold surface was almost fully covered by a thick layer in the two groups with 
BMP2 loading. But it was hard to determine whether this heavily deposited layer was 
the cell or secreted ECM layer or even both of them. At week1, it was still able to tell 
the morphology of differentiated BMSC, which were solidly anchored on the scaffold 
surface and spread out and formed a porous network. The GMs were also covered by 
clusters of BMSC and became partially eroded. From this morphology, it told that the 
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osteogenic pre-differentiation of BMSC already started at week1 and BMSC already 
started to differentiate into osteoblast. There was no obvious difference on BMSC 
morphology and ECM deposition between the three different BMP2 loading groups at 
this time point. The difference became a bit more obvious at week 3 since the two 
groups with BMP2 loading had more cells and (or) ECM coverage. 
 
Figure5.3: Expression of osteogenic gene markers for 3 weeks pre-differentiated 
BMSC on different amounts of BMP2 loaded composite scaffolds: Col I (A); ALP 
(B); OC (C). 
 
The expression of osteogenic gene markers, Col I, ALP & OC was measured at both 
week 1 & week 3 for pre-differentiated BMSC on BMP2 loaded composite scaffolds 
and shown in Figure 5.3. There was significant up regulation of Col I from week 1 to 
week 3 in all three groups. Col I was an important protein component present in bone 
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matrix or osteogeneic differentiated ECM.  Therefore the up regulation of Col I gene 
indicated the increased secretion of osteogenic ECM. But the expression level of Col I 
was not affected too much by amount of loaded BMP2 since there was no significant 
difference among the three groups.  
The expression of ALP gene saw no significant up regulation with time, but found 
significant difference among different BMP2 loading amounts of groups. At both 
week 1 and week 3, the ALP gene expression in 800ng BMP2 loaded group was 
significant higher than the other two groups. Besides, the ALP gene expression in 
400ng BMP2 loaded group was also significant higher than negative control. ALP 
was an important indicator for mineralization of the tissue at the early stage. In 
Chapter 4, it was already shown that the ALP activity was highly related with amount 
of bioactive BMP2, which explained that why higher BMP2 loading had higher ALP 
gene expression.  
Last but not least, OC gene was up regulated from week 1 to week 3 in both 400ng 
and 800ng BMP2 loaded groups. And the OC expression in 800ng BMP2 loaded 
group was significantly higher than the other two groups at both time points. Since 
OC was an osteoblast specific gene and also highly related with mineralization of 
osteogenic ECM, the expression of OC gene patterns indicated the differentiation of 
BMSC into osteoblast at week 3 and  the mineralization of the osteogenic ECM was 




Figure5.4: H&E staining of osteogenic pre-differentiated BMSC on different amounts 
of BMP2 loaded composite scaffolds: No BMP2 loaded (A); 400ng BMP2 loaded (B); 
800ng BMP2 loaded (C) 
 
Figure5.4 showed the osteogenic pre-differentiated BMSC distribution and ECM 
deposition on different amounts of BMP2 loaded scaffolds. It clearly saw the ECM 
uniform deposition on knitted silk mesh, silk fibroin sponge and GMs. However, 
more cells were detected in 800ng BMP2 loaded scaffold, as shown in Figure 5.4C, 
especially around the neighbouring area of GMs, which indicated that the high 
amount of BMP2 loaded GMs formed an attractive site for cell recruitment and 
migration, and probably enhanced the cell proliferation and differentiation.  
 
Figure5.5: Alizarin red staining of osteogenic pre-differentiated BMSC on different 
amounts of BMP2 loaded composite scaffolds: No BMP2 loaded (A); 400ng BMP2 
loaded (B); 800ng BMP2 loaded (C) 
 
Figure 5.5 showed the alizarin red staining of the calcium deposition on ECM 
secreted by osteogenic pre-differentiated BMSC on different amounts of BMP2 
loaded composite scaffolds. Overall, the calcium ions were stained throughout the 
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scaffold, but the strongest staining of them was detected around GMs. This could be 
explained in the same way as cell aggregation around GMs occurred in H&E staining. 
GMs was directly loaded with BMP2 and formed nuclear site for concentrated BMP2 
release, therefore BMSC which was attracted to GMs were highly differentiated into 
osteoblasts and secreted the highly mineralized ECM under localized BMP2 induction. 
5.3.2 BMSC Pre-Differentiated into Chondrogenic Lineage 
 
Figure5.6: Confocal microscopy imaging of chondrogenic pre-differentiated BMSC 
on different amounts of TGF-β3 loaded composite scaffolds after 3 weeks culturing: 
No TGF-β3 loaded (A); 125ng TGF-β3 loaded (B); 250ng TGF-β3 loaded (C) 
 
Figure 5.6 showed the confocal microscopy images of chondrogenic pre-differentiated 
BMSC on different amounts of TGF-β3 loaded composite scaffolds after three weeks 
culturing. Compared with osteogenic pre-differentiated BMSC, the chondrogenic pre-
differentiated BMSC had bigger cell size and was less elongated and more like round 
shape which was a bit similar to native chondrocyte phenotype. In 250ng TGF-β3 
loaded composite scaffold, the viable pre-differentiated BMSC not only looked more 
in population but also stayed more aggregated than in the other two groups, probably 





Figure5.7: SEM characterization of chondrogenic pre-differentiated BMSC on 
different amounts of TGF-β3 loaded composite scaffolds after 1 week culture: No 
TGF-β3 loaded (A); 125ng TGF-β3 loaded (B); 250ng TGF-β3 loaded (C) 
 
Figure 5.7 showed SEM characterization of chondrogenic pre-differentiated BMSC 
morphology and ECM deposition on different amounts of TGF-β3 loaded composite 
scaffolds at week 1 time point only since ECM deposition was already confluent on 
the scaffold surfaces among all the three groups. It was again hard to distinguish the 




Figure5.8: Expression of chondrogenic gene markers for 3 weeks pre-differentiated 
BMSC on different amounts of TGF-β3 loaded composite scaffolds: Collagen II (A); 
Aggrecan (B); SOX9 (C) 
 
Figure 5.8 showed the expression of chondrogeneic gene markers of Col II, Agg and 
SOX 9 for 3 weeks pre-differentiated BMSC on different amounts of TGF-β3 loaded 
composite scaffolds. As chondrogenic specific protein genes, both Col II and Agg 
were significantly up regulated from week 1 to week 3 in both TGF-β3 loaded 
scaffold groups. However, there was no significant up regulation of these two genes 
in no TGF-β3 loaded group with time and no Agg gene expression at all at week1. 
The Agg gene expression levels were also low in both TGF-β3 loaded scaffold groups 
at week 1, but followed by sharp increase at week 3, which was at least 14 fold 
change. Although the Agg gene expression occurred in no TGF-β3 loaded group at 
week 3, but it was just at the base level, significantly much lower than the other two 
groups. Different from Agg expression, the Col II expression in 250ng TGF-β3 
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loaded group had highest level and significantly higher than the other two groups at 
week 3.  
The SOX9 gene, which was the transcriptional factor for chondrogenesis, was 
significantly down regulated from week 1 to week 3 in both no TGF-β3 loaded and 
125ng TGF-β3 loaded groups. There was also a decrease in 250ng TGF-β3 loaded 
group from week 1 to week 3, but the decrease was not significant. In addition, there 
was no significant difference of this gene expression among all the three groups at the 
same time point. 
 
Figure5.9: H&E staining of 3 weeks chondrogenic pre-differentiated BMSC on 
different amounts of TGF-β3 loaded composite scaffolds: No TGF-β3 loaded (A, D); 
125ng TGF-β3 loaded (B,E); 250ng TGF-β3 loaded (C, F) 
 
Figure5.9 showed H&E staining of 3 weeks chondrogenic pre-differentiated BMSC 
on different amounts of TGF-β3 loaded composite scaffolds. There was no detectable 
difference of the cellular distribution and ECM deposition between two TGF-β3 
loaded groups. However, it was obvious to find that no TGF-β3 loaded group had less 




Figure5.10: Alician blue staining of GAG in 3 weeks chondrogenic pre-differentiated 
BMSC on different amounts of TGF-β3 loaded composite scaffolds : No TGF-β3 
loaded (A, D); 125ng TGF-β3 loaded (B,E); 250ng TGF-β3 loaded (C, F); black 
arrows indicating  the direction of from inner to outer in the rolled up scaffold) 
 
Figure5.10 showed Alician blue staining of GAG in 3 weeks chondrogenic pre-
differentiated BMSC on different amounts of TGF-β3 loaded composite scaffolds.  
Since GAG was a specific chondrogenic ECM component, the occurrence of GAG 
staining in composite scaffolds indicated the success of the BMSC chondrogenic pre-
differentiation. The 250ng TGF-β3 loaded scaffold group seemed to have most GAG 
staining, which was observed evenly distributed throughout the thickness of the 
scaffold, while in the other two groups, GAG staining was detected more likely in the 
outer surface of scaffolds. But it was obviously seen that 125ng TGF-β3 loaded group 




Figure 5.11: Immunohistochemistry staining of Col II in 3 weeks chondrogenic pre-
differentiated ECM on different amounts of TGF-β3 loaded composite scaffolds:  No 
TGF-β3 loaded (A, D); 125ng TGF-β3 loaded (B, E); 250ng TGF-β3 loaded (C, F) 
 
Figure5.11 showed immunohistochemistry staining of Col II in 3 weeks chondrogenic 
pre-differentiated ECM on different amounts of TGF-β3 loaded composite scaffolds. 
Overall, Col II staining was more evenly distributed among all the three groups as 
compared to GAG staining. Again the staining was strongest in 250ng TGF-β3 loaded 




5.3.3 BMSC Pre-differentiated into Fibroblastic Lineage 
 
Figure 5.12: Confocal microscopy imaging of viable fibroblastic pre-differentiated 
BMSC on different amounts of bFGF loaded composite scaffolds after 3 weeks 
culturing: No bFGF loaded (A); 200ng bFGF loaded (B); 400ng bFGF loaded (C) 
 
Figure5.12 showed confocal microscopy imaging of viable fibroblastic pre-
differentiated BMSC on different amounts of bFGF loaded composite scaffolds after 
3 weeks. The viable fibroblastic induced BMSC looked like spindle structure, which 
was small and elongated. This was quite similar to native fibroblasts, indicating the 
success of BMSC pre-differentiation into the fibroblastic lineage after 3 weeks 
culturing and induction. Again most viable fibroblastic pre-differentiated BMSC was 
detected in higher amount of bFGF loaded scaffold group.  
 
Figure 5.13: SEM characterization of fibroblastic pre-differentiated BMSC on 
different amounts of bFGF loaded composite scaffolds after 1 week culture: No bFGF 




Figure 5.13 showed SEM characterization of fibroblastic pre-differentiated BMSC on 
different amounts of bFGF loaded composite scaffolds after 1 week culture. Again the 
scaffold surfaces in all the three groups were completed covered due to the over 
confluence of the cells and (or) ECM deposition.  
 
Figure 5.14: Expression of fibroblastic gene markers for 3 weeks pre-differentiated 
BMSC on different amounts of bFGF loaded composite scaffolds: Col I (A); Col III 
(B); Ten C (C) 
 
Figure 5.14 showed the expression of fibroblastic gene markers for 3 weeks pre-
differentiated BMSC on different amounts of bFGF loaded composite scaffolds.  
Overall, there was no significant increase of all the three fibroblastic genes from week 
1 to week 3, only except that Col I showed up regulation in 400ng bFGF loaded group 
and Col III showed up regulation in 200ng bFGF loaded group. Besides, there was no 




Figure 5.15: H&E staining of fibroblastic pre-differentiated BMSC on different 
amounts of bFGF loaded composite scaffolds after 3 weeks culturing: No bFGF 
loaded (A,D); 200ng bFGF loaded (B,E); 400ng bFGF loaded (C,F) 
 
Figure 5.15 showed H&E staining of fibroblastic pre-differentiated BMSC on 
different amounts of bFGF loaded composite scaffolds after 3 weeks culturing. 400ng 
bFGF loaded composite scaffolds had most abundant ECM deposition and cellular 
distribution. The other two groups had comparable H&E staining. The confocal 
microscopy imaging also showed that 400ng bFGF group had most abundant viable 





Figure 5.16: Immunohistochemistry staining of fibroblastic ECM proteins of Col I 
(A,B,C), Col III(D,E,F), TenC (G,H,I) for 3 weeks pre-differentiated BMSC on 
different amounts of bFGF loaded composite scaffolds: No bFGF loaded (A,D,G); 
200ng bFGF loaded (B,E,H); 400ng bFGF loaded (C,F,I) 
 
The immunohistochemistry staining of Col I, Col III and Ten C on different amounts 
of bFGF loaded composite scaffolds was shown in Figure 5.16. 400ng bFGF loaded 
group saw most Col I & Col III staining, while no bFGF group had least Col I & Col 
III staining.  TenC staining didn’t see obvious difference among all the three groups 





5.4.1 The Effect of Different Growth Factor Loading on BMSC Tri-Lineage 3D 
Pre-Differentiation  
From both gene expression and histology results, it was concluded that the BMSC tri-
lineage 3D pre-differentiation was successfully induced on growth factor loaded 
composite scaffold under individually induced medium. The negative control group 
without growth factor had no significant up-regulation of most of specific lineage 
gene markers with time.  For example, no BMP2 loaded composite scaffold had no 
up-regulation of ALP & OC for osteogenic differentiation, and no TGF-β3 loaded 
composite scaffold had no Col II & Agg being up regulated. This indicated the 
importance of growth factor for BMSC 3D pre-differentiation.  
In BMSC 2D tri-lineage differentiation, two different concentration of growth factor 
solution were introduced and the effect of concentration difference on the 
differentiation was studied. It was found that the higher concentration was not 
necessary to have better differentiation. Similarly, two different growth factor loading 
amounts were designed and compared for BMSC tri-lineage 3D pre-differentiation in 
order to determine the optimal growth factor loading.  
In 2D study, the range of growth factor concentration was between 10ng/ml to 
50ng/ml by refreshing the growth factor solution every three days. In 3D study, the 
growth factor was loaded and lyophilized in the scaffolds in once time.  Therefore the 
growth factor was loaded in a total amount ranging from 125ng to 800ng in order to 
keep at least three weeks pre-differentiation and based on approximation of the 




After analyzing both gene expression and phenotype results consisting of cell 
morphology, ECM deposition as well as ECM protein staining, it was concluded that 
higher loading of growth factor enhanced BMSC tri-lineage 3D differentiation more 
than lower loading of growth factor, which was different from the 2D tri-lineage study.   
5.4.2 The Influence of Embedded GMs on BMSC Tri-Lineage 3D Pre-
Differentiation  
GMs embedded in the scaffolds showed very strong signals in confocal microscopic 
imaging, histological staining as well as immunohistochemistry staining. This might 
be partially due to the strong auto-fluorescence due to cross-linking of GMs as 
reported in other studies[109, 110]. Moreover, it was also found that the cross-linking 
affected other biological derived scaffold fluorescence properties, such as collagen 
hydrogels. Strong auto-fluorescence was detected in collagen hydrogel cross-linked 
by genipin[111].  However, this might also be the signal from abundant viable cells 
attracted and attached on the GMs. The localized delivery of growth factor made it 
more attracting recruit the cell than the silk fibroin sponge. In other way, 
microspheres had large surface area to volume ratio than porous scaffolds, therefore 
providing more anchor sites for the anchorage dependent cell, such as BMSC. 
Referring to osteogenic differentiation SEM pictures at week 1, it could clearly see 
that the GMs were partially degradedly and GMs were wrapped by abundant cells, 




Chapter 6 Integration of Tri-Lineage Pre-Differentiated BMSC into 
One Scaffold Complex and Study the Bone-Ligament Interface 




It was already discussed in previous chapters that the in vitro bone-ligament interface 
regeneration had to go through the individual lineage induction first for regeneration 
of each tissue component in the interface. This chapter described the study to put the 
three lineages together to form an integrated bone-ligament interface and the further 
differentiation of each lineage under co-culturing conditions. 
The overall strategy was to form the integrated structure through the sequential 
placement of the tri-lineage pre-differentiated BMSC (i.e osteogenic, chondrogenic, 
fibroblatics) into a scaffold complex, which followed the native bone-ligament 
anatomic structure. Moreover, one half of the chondrogenic scaffold piece was 
overlapped with the osteogenic piece and the other half was overlapped with half the 
fibroblast piece. The integrated bone-ligament graft was therefore constructed and 
further co-cultured in common proliferative medium. And it was hypothesized that 
each pre-differentiated lineage would further differentiate in the common medium and 
the chondrogenic lineage was finally divided into calcified fibrocartliage in the 
overlapped and co-cultured part with the osteogenic lineage and uncalcified 
fibrocartilage in the overlapped and co-cultured part with the fibroblastic lineage.  
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6.2 Methods & Materials 
6.2.1 Construction of the Integrated Bone-Ligament Interface 
 
Figure 6.1: Schematic illustration of construction of the integrated bone-ligament 
interface (solid line cross indicating the suturing knot combing chondrogenic lineage 
and fibroblastic lineage, dotted line cross indicating the suturing knot combing the 
chondrogenic lineage and osteogenic) 
 
Figure 6.1 illustrated how the tri-lineage pre-differentiated BMSC was integrated into 
one scaffold complex as well as the process of study the regeneration of bone-
ligament interface in vitro. Firstly, the BMSC was tri-lineage pre-differentiated 
individually in 1
st
 3 weeks, and then the pre-differentiated tri-lineage BMSC was 
ready to integrate in the sequence of the osteogenic, chondrogenic and fibroblastic 
from left to right, as illustrated in step 1. Then the tri-lineage BMSC was integrated 
into one scaffold complex by suturing and two suturing knots were formed as shown 
in step 2. In order to distinguish each lineage after integration, the suturing knots were 
formed at two different sides of the scaffold complex. Moreover, during integration, 
the chondrogenic scaffold was overlapped with both of the other two lineage scaffolds, 
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the middle line indicating that the chondrogenic piece was evenly divided into two 
half regions. Left half was overlapped with the osteogenic scaffold while right half 
was overlapped with the fibroblastic scaffold. Therefore the integrated bone-ligament 
scaffold complex was constructed by step 2 and it was co-cultured in common 
proliferative medium for another 3 weeks. By total up to 6 weeks, the integrated 
scaffold complex was separated by cutting the suturing knots, leaving each lineage 
scaffold detached and analyzed individually as illustrated in step 3. The chondrogenic 
scaffold was further cutting into two halves, which was labelled as A & B as shown in 
step4. The part A was the half overlapped with the osteogenic scaffold and supposed 
to differentiate into calcified fibrocatilage, while the part B was the half overlapped 
with the fibroblastic scaffold and supposed to maintain the differentiation into 
uncalcified fibrocatilage. Figure 6.2 showed the images how the integration of the tri-
lineage pre-differentiated BMSC was done by suturing. Figure 6.3 showed co-
culturing of the integrated scaffold complex and it was noticeable that the O-Ring was 




Figure 6.2: Images showing the integration of the pre-differentiated tri-lineage BMSC 




Figure 6.3: Images showing the co-culturing of the integrated scaffold complex in 6 
well plate and common proliferative medium: the front side (A), the back side (B), 
culturing with O-Ring onto the scaffold(C) 
 
6.2.2 Design of Different Control Groups for In Vitro Bone-Ligament Graft 
Co-Culture Study  
In order to show the success of in vitro bone-ligament interface regeneration under 
co-culture conditions, both negative control groups and positive control groups were 
introduced for each lineage. Table 6.1 summaries the different control groups for co-
culture study for each lineage. There are total four (n=4) different control groups in 
each lineage (including one sample group). In one control group per each lineage, 
triplicate of samples were cultured for gene expression analysis, while duplicate of 
samples were cultured for histology staining analysis. Therefore, total number of 5 
pieces of samples (n=5) is prepared for each control group in each lineage.  
All control group samples were all cultured in 24 well plates with 1ml culture medium, 
except the co-cultured group with three pieces integrated were transferred to 6 well 




Table 6.1: Summary of different control groups for bone-ligament graft co-culture 
study (n=4* as group number per lineage, n=5** as sample number per each group ) 




 3 weeks pre-differentiated 
 in induced medium 
 




 3 weeks pre-differentiated 
+ 2
nd
 3 weeks cultured  
in normal medium 
 
wk3-ost-wk6-nor wk3-cho-wk6-nor N.A 
Positive:  
6 weeks differentiated   
in induced medium 
 




 3 weeks pre-differentiated  
+ integrated by suturing  
+2
nd
 3 weeks co-cultured 





6.2.3 Postoperative Evaluation of Co-Culture Samples after 6 Weeks 
After total 6 weeks culturing, all the samples were collected. For co-culture group, the 
integrated scaffold samples were detached by cutting the suturing knots, and the 
chondrogenic scaffold piece was further cut into two even parts and part A was 
labelled as wk3-chon-wk6-co/o and part B was labelled as wk3-chon-wk6-co/f. The 
labelling of other groups was listed in table 6.1. Triplicate of samples of each group 
were harvested for total RNA extraction as well as marker genes expression 
quantification by RT-PCR. Moreover, both parts A & B of chondrogenic piece were 
characterized by hypertrophic cartilage gene markers, such as Col X and MMP13, of 
which primer sequences were designed from porcine gene sequences obtained from 
NCBI GeneBank, using Primer 3 software and then verified by BLAST. Table 6.2 
summarizes the two genes’ primer sequences. Then duplicate of samples of each 
group were harvested for histological or immunohistochemistry staining, following 
the procedures stated in Section 5.25.  
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Table 6.2: Primer sequences of the hypertrophic cartilage gene markers 
Gene Name Primer Sequence 
COL X 
F: GGA TTC CCT GGC TCT AAA GG 
R: TCC TGT TAC TCC CTG GTT GG 
MMP13 
F: TAC CAT TCA AGA TGC ACC CA 
R: TTC CAG CAG GAT TCA TAG GG 
 
Figure 6.4 showed the schematic diagram for preparation of detached scaffold for 
histological sectioning. The detached scaffold was rolled up and sectioned 
transversely for histology analysis. Besides, Alizarin red staining of two parts of the 
detached chondrogenic scaffold was done to investigate the occurrence of 
calcification of the chondrogenic scaffold after co-culture.  
 
Figure 6.4: Schematic showing preparation of the detached scaffold for histological 
sectioning. 
6.2.4 Statistical analysis 
Statistical analysis was taken for gene expression results. All data were expressed as 
mean ±standard derivation (SD). Significance analysis was performed by pairwise 
comparison of experimental groups (n=3) using two-tailed, unpaired student T-test, 





6.3.1 Gene Expression Results of 6 Weeks’ Co-Culture Study 
 
Figure 6.5: Expression of osteogenic gene markers for the detached osteogenic 
scaffold from integrated bone-ligament scaffold complex after total 6 weeks of co-
culture study: Col I (A); ALP (B); OC (C) 
 
As shown in Figure 6.5, both Col I and ALP genes expression had no significant 
difference between wk3-ost, w6-ost and wk3-ost-wk6-co groups, indicating that the 
co-cultured scaffold could keep osteogenic ECM deposition and induced cellular ALP 
activity. The negative control group wk3-ost-wk6-nor had decreasing Col I and ALP 
expression compared to wk3-ost, but the expression was not significantly down 
regulated, indicating that shifting to non-induced normal proliferation medium after 3 
weeks didn’t dedifferentiate the osteognesis. However, compared to wk6-ost and 
wk3-ost-wk6-co groups, the negative control group’s expression was still significantly 
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lower indicating the osteoegenic differentiation couldn’t go further only under 
proliferation medium, while the co-culture group could keep further differentiation 
after integration.  
The osteocalcin(OC) gene expression for co-culture group was different from the 
other two genes since it was significantly down regulated as compared to wk 3-ost 
and wk6- ost group, same as negative control group.  
 
 
Figure6.6: Expression of fibroblastic gene markers for the detached fibroblastic 
scaffold from integrated bone-ligament scaffold complex after total 6 weeks of co-
culture study: Col I (A), Col III (B), TenC (C) 
 
 
All three fibroblastic ECM protein gene markers Col I, Col III & Ten C showed 
significant up regulation for wk3-fib-wk6-co group as compared to both wk3-fib and 
wk6-fib groups, as shown in Figure6.6, which implied that the fibroblastic 
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differentiation was well maintained in co-culture group and even better than the 
groups with conditioning medium supplements.  
 
 
Figure 6.7: Expression of fibro-cartilage gene markers (A,B,D,E) and hypertrophic 
fibro-cartilage gene markers (C, F) for two half parts of detached chondrogenic 
scaffold from integrated bone-ligament scaffold complex after total 6 weeks of co-
culture.  
 
Compared to both osteogenic part as well as fibroblastic part, the gene expression of 
both fibro-cartilage markers and hypertrophic fibro-cartilage markers from detached 
chondrogenic parts of the integrated graft was not as expected. As shown in Figure6.7, 
both chondrogenic parts of co-culture groups(wk3-cho-wk6-co/o & wk3-cho-wk6-
co/f) had significant down regulation of fibro-cartilage ECM protein markers of Col I , 
Col II, Agg only except that the chondrogenic transcription factor gene SOX 9 
maintained the expression as compared to wk3-cho and had no significant difference 




However, the hypertrophic cartilage gene markers, Col X & MMP13 were 
significantly up-regulated for chondrogenic part A co-cultured with osteogenic 
lineage, as compared to all the other groups. Besides, there was no significant up 
regulation of these two genes for chondrogenic part B co-cultured with fibroblastic 
lineages, indicating the calcification only occurring in part A.  
6.3.2 Histological Staining Results of 6 Weeks’ Co-Culture Study 
6.3.2.1 Histological Staining of Detached Osteogenic Scaffold from Integrated B-
L Scaffold Complex 
 
Figure6.8: H&E staining of detached and rolled up osteogenic scaffold from 
integrated B-L scaffold complex after total 6 weeks of co-culture study: wk3-
ost(A,E,I); wk3-ost-wk6-nor(B,F,J); wk6-ost(C,G,K) and wk3-ost-wk6-co(D,H,L) 
(Black box indicating the area to be further magnified; red arrows indicating the 
direction from inner to outer after rolling up the scaffold) 
 
H&E staining in Figure 6.8 showed the transverse cellular distribution and ECM 
deposition of the detached and rolled up osteogenic scaffold after total culture of 6 
weeks. Overall, all the groups cultured up to 6 weeks demonstrated more cell number 
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and ECM deposition than week 3 base group, which varied from gene marker 
expression results. The gene results all showed lowest expression in negative control 
group, which was wk3-ost-wk6-nor. Besides, the positive control group had most 
abundant cellular distribution and ECM deposition, followed by the co-culture group. 
This might indicate that the cell proliferation and ECM deposition were not affected 
by changing of the culture medium, but more related with the culturing time period. 
But conventionally induced medium did enhance ECM deposition, probably due to 
more osteogenic ECM formation under induced medium. Meanwhile, direct contact 
and co-culturing of osteogenic lineage with the chondrogenic lineage also helped 
produce more ECM, probably due to more active cellular interaction between these 
two lineages. Overall, H&E staining showed that the BMSC proliferation as well as 
osteogenic ECM formation was well maintained after the scaffold complex was 





Figure6.9: Alizarin red staining of detached and rolled up osteogenic scaffold from 
integrated B-L scaffold complex after total 6 weeks of co-culture study: wk3-
ost(A,E,I); wk3-ost-wk6-nor(B,F,J); wk6-ost(C,G,K) and wk3-ost-wk6-co(D,H,L) 
(Black box indicating the area to be further magnified; white arrows indicating the 
direction from inner to outer after rolling up the scaffold) 
 
Alizarin red staining results were similar to H&E staining, as shown in Figure 6.9 that 
the wk3-ost group had least calcium staining, while all other groups cultured to 6 
weeks had more calcium deposition within the same staining area. However, the co-
culture group wk3-ost-wk6-co had slight less staining intensity than other 6 weeks 
culture group. It might indicate that co-culturing with chondrogenic lineage may have 
slight inhibition on the mineralization for the osteogenic part. And it was interesting 
to find that both negative and positive control group had comparable calcium staining. 
It was probably explained that the first three weeks osteogenic pre-differentiation had 
already accumulated certain calcium deposition and served as calcium nuclear site for 
further calcification, therefore compromising the lack of β-glycerphosphate in the 
common proliferative medium during 2
nd
 three weeks culturing. Overall, from the 
alizarin red staining results, it proved the hypothesis that the normal proliferation 
medium would  not affect the further calcification of osteogenic part of the integrated 
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scaffold complex, while the co-culture with chondrogenic lineage did maintain BMSC 
proliferation, differentiation and osteogenic ECM deposition, although it slightly 
decreased the mineralization.   
6.3.2.2 Histological Staining of Detached Fibroblastic Scaffold from 
Integrated B-L Scaffold Complex 
 
Figure6.10: H&E staining of detached and rolled up fibroblastic scaffold from 
integrated B-L scaffold complex after total 6 weeks of co-culture study: wk3-
fib(A,D,G); wk6-fib(B,E,H) and wk3-fib-wk6-co(C,F,I) (Black box indicating the 
area to be further magnified; red arrows indicating the direction from inner to outer 
after rolling up the scaffold) 
 
In Figure6.10, the fibroblastic part showed more abundant cellular distribution as well 
as ECM deposition for two 6 weeks culture groups than 3 weeks culture group.  
Besides, co-culture group showed slight more ECM deposition than wk6-fib group. 
This might be due to active cell interaction of fibroblastic lineage with surrounding 
chondrogenic lineage, which enhanced the cell migration and proliferation. Looking 
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back to the gene expression results, co-culture group also demonstrated highest ECM 
protein gene expression than other two groups. To this point, co-culturing with 
chondrogenic lineages enhanced fibroblastic BMSC proliferation and ECM deposition.  
 
Figure6.11: Immunohistochemistry staining of Col I(A,B,C), Col III(D,E,F) & TenC 
(G,H,I) protein of detached and rolled up fibroblastic scaffold from integrated B-L 
scaffold complex after total 6 weeks of co-culture study: wk3-fib(A,D,G); wk6-
fib(B,E,H) and wk3-fib-wk6-co(C,F,I) 
 
The staining of three fibroblastic ECM proteins was a bit different from their gene 
expression result since Figure 6.11 showed most staining of Col III and Ten C in wk6-
fib group although most staining of Col I still occurred in co-culture group. Again, 
two 6 weeks culture groups demonstrated more staining of three proteins than 3 
weeks culture group, which was consistent with both gene expression result and H&E 
staining result. Overall, co-culturing with chondrogenic lineage didn’t enhance further 
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fibroblastic differentiation, but did enhance the fibroblastic BMSC proliferation and 
ECM deposition. 
6.3.2.3 Histological Staining of Detached Chondrogenic Scaffold from Integrated 
B-L Scaffold Complex 
 
Figure6.12: H&E staining of detached and rolled up chondrongenic scaffold from 
integrated B-L scaffold complex after total 6 weeks of co-culture study: wk3-
cho(A,F,K);wk3-chon-wk6-nor(B,G,L);wk6-cho(C,H,M);wk3-cho-wk6-co/o (D,I,N); 
wk3-cho-wk6-co/f (E,J,Q)(Black box indicating the area to be further magnified; red 
arrows indicating the direction from inner to outer after rolling up the scaffold) 
 
The two detached chondrogenic scaffold parts showed similar pattern of H&E 
staining results as the other two lineages, which was that all 6 weeks culture groups 
had more cellular distribution and ECM deposition than 3 weeks group, as shown in 
Figure6.12. However, the two subdivided chondrogenic parts demonstrated different 
staining results. The part A co-cultured with osteogenic part (wk3-cho-wk6-co/o) 
showed slightly more abundant and uniform cellular distribution as well as ECM 





Figure6.13: Alician blue staining of GAG deposition of detached and rolled up 
chondrongenic scaffold from integrated B-L scaffold complex after total 6 weeks of 
co-culture study: wk3-cho(A,F,K);wk3-chon-wk6-nor(B,G,L);wk6-cho(C,H,M);wk3-
cho-wk6-co/o (D,I,N);wk3-cho-wk6-co/f(E,J,Q)(Black box indicating the area to be 
further magnified; red arrows indicating the direction from inner to outer after rolling 
up the scaffold) 
 
Besides, Alician blue staining in Figure 6.13 demonstrated uniform GAG deposition 
across the thickness of the scaffold for all the groups. The co-cultured chondrogenic 
part A (wk3-cho-wk6-co/o) showed highest density of blue GAG staining among all 
the five groups. However, another co-cultured chondrogenic part B (wk3-cho-wk6-







Figure 6.14: Immunohistochemistry staining of Col I (A,B,C,D,E) , Col II (F,G,H,I,J) 
& Col X (K,L,M,N,O) protein of detached and rolled up chondrongenic scaffold from 




Figure 6.14 showed immunohistochemistry staining of two half parts of the detached 
chondrogenic scaffold. Col I & Col II staining was done to characterize the deposition 
of specific fibrocartilage ECM proteins, and Col X staining was done to demonstrate 
the calcification of the fibrocatilage into hypertrophic fibrocartilage. Col I staining 
was obviously observed in week 6 positive control and two week 6 co-culture groups 
also, while Col II staining was detected in all groups. The positive control 
demonstrated strongest signal of Col II staining, followed by week 3 base group, 
which was consistent with Col II gene expression results. But two co-culture groups 
also showed detectable Col II staining, and negative control only showed slight 
staining in the outer layer of the scaffolds. The chondrogenic part A (wk3-cho-wk6-
co/o) demonstrated strongest staining of Col X, while all other groups showed very 





Figure 6.15: Alizarin red staining of calcification of two detached and rolled up of 
chondrogenic scaffolds from the integrated B-L scaffold complex after total 6 weeks 
of co-culture study: wk3-cho-wk6-co/o (A, C, E) and wk3-cho-wk6-co/f (B, D, F) 
(Black box indicating the area to be further magnified; white arrows indicating the 
direction from inner to outer after rolling up the scaffold) 
 
Last but not least, Alizarin red staining was done and compared between 
chondrogenic parts A and B to confirm the transfer of uncalcification to calcification 
in part A and maintaining of uncalficiation in part B. As seen in Figure6.15, the co-
cultured chondrogenic part A with osteogenic lineage did show much stronger red 




6.4.1 Maintaining of Tri-Lineage Pre-Differentiation up to 6 Weeks  
It was hypothesized that after 1
st
 three weeks of tri-lineage pre-differentiation of 
BMSC on individual scaffold and conventionally induced medium, further 
differentiation could still happen under co-culturing in common non-induced 
proliferative medium. For osteogenic and fibroblastic lineage differentiation, both 
gene expression and histology staining results confirmed this hypothesis. However, 
chondrogenic lineage differentiation proved this hypothesis from histological staining 
results only.  
For quantitative gene expression, osteogenic differentiation saw both Col I & ALP 
genes’ increasing expression in co-culture group as compared to week 3 base control 
as well as comparable expression compared with week 6 positive control, only except 
OC gene showing significant down regulation in co-culture group as compared to 
both base and positive controls.  Col I gene was not bone specific marker, but this 
protein was considered as a very important component of osteogenic ECM and the 
gene was an early indicator for osteogenic differentiation. ALP gene was neither bone 
specific, but highly related with cellular activity and also an early indicator for 
osteogenic differentiation. While OC gene was one of the few osteoblastic specific 
gene and found to be highly related with osteogenic ECM mineralization[112]. 
Therefore, it might indicate the mineralization of the osteogenic ECM was affected 
while the osteogenic ECM deposition and cellular differentiation was still well 
maintained when shifting to the co-culturing in proliferative medium. Besides, H&E 
staining of the detached osteogenic scaffold in co-culture group had better cellular 
proliferation as well as ECM deposition than both week 3 base and week 6 negative 
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controls, which was consistent with gene expression results.  The Alizarin red staining 
did show slight less calcium deposition than week 6 negative control yet still 
significant more than week 3 base control. Both gene and histological staining results 
probably indicated that the osteogeneis could maintain further differentiation in terms 
of continuous osteogenic BMSC cellular activity and ECM deposition, but the 
mineralization was just slightly decreased when osteogenic differentiated BMSC was 
under direct contact of co-culture with chondrogenic differentiated BMSC in normal 
proliferative medium. Similar finding was reported in Jiang’s study of co-culture of 
osteoblalsts and chondrocytes in vitro[113] that cellular ALP activity was maintained 
in the osteoblasts while the mineralization was markedly lower. But in this study, 
probably due to the pre-calcification in the 1
st
 three weeks, the further mineralization 
was not affected too much, since the alizarin red staining of the co-culture group at 
week 6 still showed more than that in week 3 base group.  
For the fibroblastic lineage further differentiation, the co-culture group showed 
significant up regulation as compared with both week 3 and week 6 controls in terms 
of all three fibroblastic ECM protein gene markers. Besides, H&E staining in co-
culture group also showed most cellular distribution and ECM deposition in 
fibroblastic co-culture group as compared the other two controls. However, the 
immunohistochemistry staining of Col III & TenC ECM component in co-culture 
groups showed slight less than week 6 non co-culture control while Col I staining was 
still most.  
For chondrogenic lineage, since the co-culture group scaffold was overlapped and co-
cultured with two different lineages, the results were analyzed separately. Both 
subdivided chondrogenic parts of co-culture group showed down regulation for 
fibrocartilage gene markers of Col I, Col II and Aggrecan as compared to week 3 base 
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group while the early chondrogenic transcriptional gene marker SOX9 still 
maintained the comparable expression with week 3 base and week 6 positive controls. 
However, H&E staining of both chondrogenic part A & B of the co-culture group 
showed comparable cellular distribution, ECM deposition, GAG deposition with 
week 6 positive control group and better staining than week 3 base group. Besides, 
chondrogenic part A showed most GAG staining than all other groups, and part B 
showed less GAG staining than positive control, but still better than week 3 control. 
Moreover, both chondrogenic parts saw detectable Col I & Col II staining, although 
less than week 6 positive control, but their Col I staining was more than week 3 base 
control and Col II staining was comparable with week 3 base control.  So it could be 
concluded that that both of two chondrogenic parts in the co-culture group could 
maintain further fibrocatilage differentiation but the co-culturing with osteogenic 
lineage enhanced the differentiation more than co-culturing with fibroblastic lineage. 
In both Zuo[114] and Liu’s[115] study, it investigated the chondrogenesis of BMSC 
co-cultivated with chondrocytes in both direct contact co-culture and non-direct 
contact co-culture models. They both hypothesized that the secreting soluble factors 
and/or physical cell-cell contact might contribute to BMSC chondrogenesis. However, 
their conclusions were different.  Zuo[114] concluded that the physical contact played 
a more predominant role than soluble factors in BMSC chondrogenesis since direct 
contact co-culture had higher expression of chondrogenic markers than no direct 
contact co-culture, while Liu[115] believed that it was the soluble factors secreting 
from chondrocytes provided the chondrogenesis signals rather than the cell-cell 
contact. But Liu also pointed out that the concentration of the soluble factors in the 
co-culturing medium was much lower than those currently used in conventionally 
chondrogenic induced medium. This might support that why the pre-differentiated 
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chondrogenic BMSC showed down regulation of fibrocatilage gene markers when 
shifting to normal proliferative medium even with direct co-culture with pre-
differentiated osteogenic and fibroblastic BMSC.  
Furthermore, in Kim’s study of the osteogenesis and angiogenesis with co-cultured 
ADSC and BMSC[116], the influence of different paracrine signalling pathways due 
to secretion of different soluble factors from different lineage were deeply 
investigated. The osteogenesis and angiogenesis pathways were synergic since the 
TGF-β/SMAD pathway in angiogenesis up-regulated the Wnt5a, which was highly 
related with osteogenic differentiation of BMSC[116]. Even though there was down 
regulation of fibrocartilage gene markers in both sub-divided chondrogenic parts, the 
chondrogenic part co-cultured with osteogenic scaffold still had better staining of Col 
I, Col II, GAG staining than week 3 base group, which might be explained by that 
BMSC osteogenesis and chondrogenesis also had the synergetic signalling pathway, 
similar as the mechanism for synergetic signalling between osteogenesis and 
angiogenesis.  
6.4.2 Formation of the Transitional Fibrocatilage Interface under Co-Culture 
between Tri-Lineage  
It was already reviewed in Chapter 2 that the native bone-ligament interface was a 
multiple tissue region and the transitional part from bone to ligament was made up of 
both calcified fibrocatilage and uncalcified fibrocartilage so that there was a smooth 
mechanical force transfer from bone to ligament. It was hypothesized the 
chondrogenic lineage induced from BMSC would keep differentiated into 
fibrocartilage and at the same time the co-culture part with osteogenic lineage could 
transfer to calcified fibrocartilage while the other part co-cultured with fibroblastic 
lineage maintained uncalcified fibrocartilage phenotype.  
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From the expression of hypertrophic gene markers Col X and MMP13, the co-culture 
part A had more expression of these two genes than co-culture part B, especially 
significant difference of Col X gene expression between these two groups.  From the 
immunohistochemistry staining of Col X, co-culture part A also showed strong 
staining than part B. Col X was an important protein in hypertrophic cartilage. 
Therefore, it indicated that co-culture part A had calcification in pre-differentiated 
fibrocatilage, while there was almost no calcification occurred in part B. Last but not 
least, alizarin red staining comparison in these two co-culture parts demonstrated the 
mineralization in part A, while no mineralization in part B, indicating the formation of 
the calcified fibrocatilage in part A. Furthermore, it could be concluded that the pre-
differentiated fibrocatilage showed formation of the transitional interface, which was 




Chapter 7 Conclusion and Recommendation for Future Work 
 
7.1 Conclusion  
 
In this project, a bone-ligament interface was finally engineered in vitro by firstly 
inducing multi-potent BMSC into tri-lineage on multiple biocompatible composite 
silk fibroin based scaffolds with different biomolecular cues, and then co-culturing of 
integrated scaffold complex from combing tri-lineage pre-differentiated BMSC. The 
interface was considered biomimic in terms of formation of the transition from 
calcified fibrocartilage to uncalcified fibrocartilage after co-culturing.  
 
In more details, this interface was developed through four stages of work. In Stage 1, 
the cell source was selected and confirmed to be the multi-potent BMSC, which was 
suitable as the only cell source to support the development of bone-ligament interface 
in vitro through 2D tri-lineage differentiation. Besides, the effects of different culture 
medium and concentration of biological cues on the BMSC differentiation was 
investigated for further 3D differentiation study as well as designing of the bone-
ligament interface. And it was finally found that there was no common medium which 
could support BMSC tri-lineage differentiation simultaneously in vitro. Moreover, the 
growth factor itself could only enhance the differentiation but not the enough 
supplements; therefore it still needed the conventionally induced culture medium 
supplements. This founding gave the guidance that BMSC 3D tri-lineage pre-
differentiation would have to take place on various scaffolds with different growth 
factor loaded as well as in different induced medium first in order to further form in 
vitro bone-ligament interface. 
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In Stage 2, a biocompatible composite scaffold was proposed to be fabricated by 
taking consideration of their functions as both 3D support for BMSC proliferation, 
differentiation and biological reservoirs for sustainable growth factor releasing. 
Therefore the composite silk fibroin scaffold with GMs embedded was fabricated by 
lyophilizing the 2wt% of fibroin solution with growth factor loaded GMs on a knitted 
silk mesh. The biocompatibility of the composite scaffold was measured both 
quantitatively through Alamar blue assay as well as qualitatively by confocal imaging 
of the FDA staining of the viable cells on the scaffold.  Both two results proved the 
little cytotoxicity of this composite silk scaffold. The interaction of the cells with the 
composite scaffold was also visualized by SEM imaging. And it was found that the 
cell was actively interacted with both GMs as well as the silk sponge wall. The release 
profiles of three different growth factors were also quantified and it was found the 
burse release of each growth factor was small and the release kinetics was almost 
linear within the measured time frame.  
 
In Stage 3, the BMSC 3D tri-lineage pre-differentiation was studied on three different 
growth factors loaded individual scaffolds as well as in three individually induced 
medium. Moreover, two different loading of each growth was designed to investigate 
the effect of growth factor loading on BMSC 3D differentiation. Both gene expression 
and histological (or immunohistochemistry) staining were done to prove the success 
of the pre-differentiation in tri-lineages and the results were as expected.  Meanwhile, 
the results of differentiation were compared for scaffolds with two different growth 
factor loading amounts in each lineage.  It was interesting to find that the optimal 3D 
loading amount was different from 2D results.  All the tri-lineage differentiation 
preferred higher loading of growth factor.  
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Last but not least, the integration of tri-lineage pre-differentiated BMSC and co-
culture of the integrated scaffold complex was studied in Stage 4 in order to form a 
the biomimic bone-ligament interface. The integration into one scaffold complex for 
bone-ligament interface regeneration was done by suturing three pieces of different 
lineages pre-differentiated BMSC using the degummed silk fiber, with the 
chondrogenic lineage staying in the middle and overlapping with the other two 
lineages.  For co-culturing, the normal proliferative medium was selected as common 
medium for further differentiation of tri-lineage. Again both gene expressions and 
histological (or immunohistochemistry) staining were analyzed to investigate the 
maintaining of tri-lineage differentiation and formation of the transitional bone-
ligament interface under co-culturing conditions.  After total 6 weeks of culturing, 
each lineage scaffold was detached from the integrated scaffold complex for 
analyzing. Moreover, the chondrogenic lineage was cut into two halves, each half was 
the part overlapped with different lineages. It was found that osteogenic and 
fibroblastic lineages maintained the further differentiation after another 3 weeks of 
co-culturing even under the common proliferative medium in terms of both gene 
expression and histology (or immunohistochemsitry) staining results. The 
chondrogenic lineage was also able to further differentiate but only in terms of the 
phenotype results, which demonstrated similar cellular proliferation, ECM deposition, 
GAG formation as well as Col I staining in both chondrogenic parts as compared to 
week 6 positive control. However, the gene expression results of fibrocatilage 
markers Col I, Col II, Agg in both chondrogenic parts was down regulated.  
Besides, it was noticed that the hypertrophic cartilage gene markers of Col X and 
MMP13 was significantly up regulated in the chondrogenic part co-cultured with 
osteogenic lineage and the staining of protein Col X also demonstrated the positive 
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results, indicating the calcification of the pre-differentiated fibrocatilage after co-
culturing with the osteogenic lineage. However, there was no Col X & MMP13 genes 
up regulated and very little Col X staining occurred in the chondrogenic part co-
cultured with fibroblastic lineage. This implied the formation of the transitional 
interface which was made up of both calcified fibrocatilage near to the osteogenic 
lineage and uncalcified fibrocartilage near to the fibroblastic lineage. This was further 
confirmed by significant difference of the alizarin red staining between the two 
chondrogenic parts, which showed much more of calcium deposition in chondrogenic 
part co-cultured with the osteogenic lineage while little calcium deposition in the part 
co-cultured with the fibroblastic lineage. 
7.2 Recommendations for Further Work 
Overall, the bone-ligament interface was successfully engineered in vitro. However, 
the fibro-cartilage gene markers were significantly down-regulated after co-culturing 
in normal proliferative medium which might be due to the limitations of the in vitro 
stimulus. Therefore extra in vitro stimulus may be added, such as a compressive 
bioreactor, which had been reported previously to increase the fibrocatilage 
regeneration for annulus fibrosus in a novel simulated inter-vertebral disk-like 
assembly[117]. Therefore, this compressive bioreactor could probably be modified 
and adapted for this project to execute the compressive force onto the chondrogenic 
part in the integrated scaffold complex to maintain the further fibrocartilage gene 
expression.   
 
Besides, in order to provide the native stem cell niches to stem cell differentiation for 
bone-ligament interface regeneration, the best option was to conduct the in vivo study 
by transplanting the integrated graft into the animal model, such as rabbit or even 
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larger animal pigs. Then the scaffold needed to be modified to form structurally 
continuous phases rather than physically integrated graft through suturing, so that the 
scaffold could stand for the tensile stretch which the graft would experience after 
transplantation. And the scaffold could be designed as illustrated in figures 7.1.  
Overall, the graft was continuous silk fibroin based composite scaffold,  but with 
three different zones embedded with different growth factor loaded gelatin 
microspheres. This multi-phasic scaffold graft could be cultured in vitro for three days 
first to allow the BMSC attachment and stabilization and then directly implanted into 
the defect size for in vivo regeneration. Under the growth factor stimulus plus the 
native stem cell niche, the BMSC were supposed to differentiate into the phenotype 
similar to surrounding tissues[118].  
 
 
Figure7.1: Schematics showing continuous multiphasic silk fibroin composite bone-
ligament graft design with three different growth factors embedded GMszones for 
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Alamar Blue Assay Reduction Calculation Formula  
The percentage of reduction of alamar blue assay was calculated based on formula 
below:
 
Where O1 and O2 are the molar extinction coefficient(E) of Oxidized alamar blue 
solution at wavelength of 570nm and 600nm respectively, while R1 and R2 are the 
molar extinction coefficient(E) of Reduced alamar blue solution at wavelength of 
570nm and 600nm respectively. Their value was already known. 
Wavelength Oxidized(O) Reduced (R) 
570nm 80586 155677 
600nm 117216 14652 
 
A1 and A2 are absorbance value of test wells at wavelength of 570nm and 600nm 
respectively, while N1 and N2 are absorbance value of blank medium at wavelength 




ALP ASSAY  
 Equilibrate PNPP to room temperature before opening.  
 Dissolve 10mg of PNPP or two PNPP Tablets in 10mL of Diethanolamine 
Substrate Buffer.  
  Add 100μL of the PNPP solution to each microplate well. Incubate plate at room 
temperature for 30 minutes or until sufficient color develops.  
 To stop the reaction, add 50μL of 2N NaOH to each well.  
 Measure the absorbance at 405nm. Alternatively, monitor reaction in a kinetic 







 The scaffold samples were collected into the micro-tube and washed with 
sterilized 1XPBS twice. 
 The washed scaffold samples were frozen in -80°C freezer overnight and 
transferred to freeze dry machine to be lyophilized for 5 hours. 
 The freeze dried scaffold was minced to powder using the  syringe needle and 
then added with 400 μl of the cell lysis buffer which made up of 360 µl of 1XTE 
buffer (diluted by 20 times from 20X TE buffer in the kit) and 40 μl of RLT 
buffer (from Qiangen RNA kit) and 1 μl of β-mercaptoethanol solution. 
 Vortex the micro-tube with lysis buffer for 5 minutes and then centrifuge at 
16,000 rpm for 5 minutes. 
 Pre-warm the fluorescence dye solution from -20 °C freezer to room temperature 
in dark and dilute the dye with 1XTE buffer by 200 times.  
 Collect 20 μl of supernatant of the lysis buffer after centrifugation and mix with 
80 μl of fluorescence dye solution by pippetting and add into transparent 96 well 
plate and cover the plate with aluminium foil to avoid the light exposure. 
 Prepare a series of diluted DNA solution from 100 μg/ml DNA standard solution 
in the kit and mix in the same ratio with fluorescence dye as the unknown DNA 
samples and add into the 96 well plate.  
 Switch on fluorescence microplate reader (FLUOstar OPTIMA) 10 minutes 
before the measurement and at the same time allow the incubation of the DNA 
solution with fluorenscence dye for 5 min. 
160 
 
 Measure fluorescence intensity at 520 nm wavelength after excitation at 485 nm, 
10 flashes per well, and a position delay time of 0.2-0.5s. The gain value are set 
by clicking on auto adjustment before the start of the measurment 
 The final DNA concentration of the samples was finally calculated based on the 







 Prepare all reagents, standard dilutions, and samples as directed in the product 
insert. 
 Remove excess microplate strips from the plate frame, return them to the 
foilpouch containing the desiccant pack, and reseal. 
 Add 100 µL of assay diluent to each well. 
 Add 50 µL of standard, control, or sample to each well. Cover with a plate sealer, 
and incubate at room temperature for 2 hours on a horizontal orbital microplate 
shaker. 
 Aspirate each well and wash, repeating the process 3 times for a total of 4 washes. 
 Add 200 µL of conjugate to each well. Cover with a new plate sealer, and 
incubate at room temperature for 2 hours on the shaker. 
 Aspirate and wash 4 times. 
 Add 200 µL Substrate Solution to each well. Incubate at room temperature for 30 
minutes on the bench top. Protect from light. 
 Add 50 µL of stop solution to each well. Read at 450 nm within 30 minutes. Set 
wavelength correction to 540 nm or 570 nm. 
 Calculate the sample concentration based on the calibration curve of standard 
solution  
 
 
